Home
  >  
Section 34

EurekaMag Full Text Articles Chapter 33,285



References:

Maupetit, J.; Gautier, R.; Tuffery, P. 2006: SABBAC online structural alphabet-based protein backbone reconstruction from alpha-carbon trace. Nucleic Acids Research 34(Sp. Iss. SI): W147-W151
Sasaki, H.; Tashiro, K.; Wakisaka, A. 1995: SAC1 and SAC2: disease loci, gene defect, and clinical phenotypes. No to Shinkei 47(2): 109-116
Eder, D.N.; Avery, D.H.; Wildschiodtz, G.; Dam, H.; Bolwig, T.G. 1998: SAD, asleep and unresponsive Sleep regulation in seasonal affective disorder. Journal of Sleep Research 7(Suppl 2): 74
Hylton, J. 1992: SAFE Stopping AIDS through functional education. Crocker, A C , Cohen, H J , Kastner, T A HIV infection and developmental disabilities: A resource for service providers : 153-160
Schloesser, U.G. 1994: SAG Sammlung von Algenkulturen at the University of Goettingen Catalogue of strains 1994. Botanica Acta 107(3): 113-186
He, H.; Gu, Q.; Zheng, M.; Normolle, D.; Sun, Y. 2008: SAG/ROC2/RBX2 E3 ligase promotes UVB-induced skin hyperplasia, but not skin tumors, by simultaneously targeting c-Jun/AP-1 and p27. Carcinogenesis 29(4): 858-865
Shukla, A.; Bajwa, P.; Bhaumik, S.R. 2006: SAGA-associated Sgf73p facilitates formation of the preinitiation complex assembly at the promoters either in a HAT-dependent or independent manner in vivo. Nucleic Acids Research 34(21): 6225-6232
Gol'dberg, S.I.; Tsibul'kin, E.K.; Rudnov, V.A.; Belyaev, S.V.; Nikolaev, E.K.; Piontek, A.E.; Savel'ev, D.A. 1997: SAGE computer software as a tool for standard assessment of patients on intensive care. Anesteziologiya i Reanimatologiya 1997(1): 11-15
Monigatti, F.; Steen, H. 2008: SALAMI (Spectrum ALignments using high Accuracy Mass and hIgh sensitivity data): how to make the best out of hybrid MS/MS data. Journal of Proteome Research 7(5): 1984-1993
Yang, J.; Chai, L.; Gao, C.; Fowles, T.C.; Alipio, Z.; Dang, H.; Xu, D.; Fink, L.M.; Ward, D.C.; Ma, Y. 2008: SALL4 is a key regulator of survival and apoptosis in human leukemic cells. Blood 112(3): 805-813
Hoyheim, B.; Danzmann, R.; Guyomard, R.; Holm, L.E.; Powell, R.; Taggart, J. 1998: SALMAP Constructing genetic maps of salmonid fishes. Animal Genetics 29(Suppl 1): 46-47
Smith, R.G.; Henry, K.; Appel, S.H. 1998: SALS immunoglobulins induce production of the cytotoxic lipid peroxidation product 4-hydroxynonenal in motor neuron hybrid cells. Journal of Neurochemistry 70(Suppl 1): S8
Simons, J.W.; Oliner, J.D.; Cho, K.R.; Kinzler, K.W.; Vogelstein, B. 1992: SAM 1.1 and JOSH 4.4: two RFLPs within the human DCC gene. Human Molecular Genetics 1(5): 352
Morley, J.E.; Kumar, V.B.; Flood, J.F. 1997: SAM P8 mice An animal model of overproduction of beta-amyloid causing impaired learning and memory. Journal of the American Geriatrics Society 45(9): S1
Joshi, C.P.; Chiang, V.L. 1998: SAM-dependent Methyltransferase-specific amino acid signatures in plants. Plant Biology (Rockville) : 52
Smith, E.R.; Nicholas, N.S.ephanie 1994: SAMAB demonstration of the National Forest Health Monitoring program. Bulletin of the Ecological Society of America 75(2 Part 2): 214
A.L.zi, M.; Pestronk, A.; Flaris, N.; Yee, W.C.; Cooper, J. 1993: SAMM syndrome A subacute myopathy with myosin-deficient fibers. Neurology 43(4 Suppl 2): A279-A280
Hübner, U.; Schuier, F.J.; Newell, J.A. 1994: SAMMIE A2032: software applied to multimodal images and education. Computer Methods and Programs in Biomedicine 45(1-2): 149-152
Takeda, T. 1993: SAMP8 and SAMP10 as new murine models for age-related deficits in learning and memory. Congenital Anomalies 33(3): 263
Lemire, E.G.; Hildes Ripstein, E.; Mcpherson, J.; Reed, M.H.; Chudley, A.E. 1996: SAMS A multiple congenital anomalies syndrome consisting of short stature, auditory canal atresia, mandibular hypoplasia and skeletal abnormalities. American Journal of Human Genetics 59(4 Suppl): A97
Guinarud, J.L.; Ammirati Mene, C.; Bordet, G.; Alberque, C.; Jouchoux, Y.; Herduin, J.C.; Nemitz, B. 1993: SAMU 80 The Mobile Operational Command Post. Urgences Medicales 12(1): 35
Gutierrez, S.; Palacios, I.; Sanchez Pernaute, O.; Hernandez, P.; Egido, J.; Herrero Beaumont, G. 1996: SAMe restores the changes in proliferation and in the synthesis of fibronectin and proteoglycans induced by TNF-alpha on cultured synovial cells. British Journal of Rheumatology 35(ABSTR Suppl 1): 63
Foy, C.L.; Witt, H.L. 1997: SAN 582, alachlor, and metolachlor control triazine-resistant smooth pigweed in no-till corn. Weed Technology 11(3): 623-625
Kobayashi, S.; Uchiyama, G. 1993: SANMITE - a new miticide. Agrochemicals Japan 1993(63): 12-14
Thiyagarajan, P.; Ku, C.Y.; Quaite Randall, E.; Joachimiak, A. 1997: SANS studies of thermal stability of the double-ring structure of E coli GroEL chaperonin in solution. Biophysical Journal 72(2 Part 2): A130
Sinibaldi, R.; Ortore, M.G.; Spinozzi, F.; de Souza Funari, S.ér.; Teixeira, J.é; Mariani, P. 2008: SANS/SAXS study of the BSA solvation properties in aqueous urea solutions via a global fit approach. European Biophysics Journal: Ebj 37(5): 673-681
Morissette, C.; Janousek, J.; Gervais, F. 1992: SAP inhibits the uptake of HDL-SAA by spleen macrophages. Journal of Leukocyte Biology 1992(Suppl 3): 22
Lafeuillade, A.; Geoffroy, M.; Pellegrino, P.; Profizi, N.; Quilichini, R. 1993: SAP levels correlate with protein S activity in HIV-1 infection. IXTH INTERNATIONAL CONFERENCE ON AIDS and THE IVTH STD WORLD CONGRESS Author IXth International Conference on AIDS in affiliation with the IVth STD World Congress : 451
Kindler, S.; Mueller, B.M.; Kistner, U.; Chung, W.J.; Kuhlendahl, S.; Lau, L.F.; Veh, R.W.; Huganir, R.L.; Gundelfinger, E.D.; Garner, C.C. 1996: SAP102, a novel postsynaptic protein that interacts with the cytoplasmic tail of the NMDA receptor subunit NR2B. Society for Neuroscience Abstracts 22(1-3): 1218
Dubois, N.; Colina, A.R.; Aumont, F.; Belhumer, P.; Derepentigny, L. 1998: SAP2 constitutive overexpression and virulence of Candida albicans. Abstracts of the General Meeting of the American Society for Microbiology 98: 257-258
Boeckers, T.M.; Kreutz, M.R.; Bockmann, I.J.; Langnase, K.; Sanmarti Vila, I.L.; Garner, C.C.; Gundelinger, F.D. 1998: SAP24e, a novel postsynaptic density protein. Society for Neuroscience Abstracts 24(1-2): 1999
Garcia, E.P.; Mehta, S.; Blair, L.A.; Wells, D.G.; Shang, J.; Fukushima, T.; Fallon, J.R.; Garner, C.C.; Marshall, J. 1998: SAP90 binds and clusters kainate receptors causing incomplete desensitization. Neuron 21(4): 727-739
Kahn, M.F. 1996: SAPHO and psoriasis. Rhumatologie 48(4): 106
Vaile, J.H.; Langlands, D.R.; Prichard, M.G. 1995: SAPHO syndrome: a new pulmonary manifestation?. Journal of Rheumatology 22(11): 2190-2191
Robins, P.D.; Blake, M.P.; Robinson, P.S. 1998: SAPHO syndrome mimicking metastases on bone scintigraphy. Clinical Nuclear Medicine 23(10): 696-698
Mundel, T.M.; Mundel, P.; Kriz, W. 1994: SAPIC, a novel protein of collecting duct intercalated cells. Journal of the American Society of Nephrology 5(3): 257
Bettini, E.; Carletti, R.; Carboni, L.; Ferraguti, F.; Tacconi, S. 1996: SAPK/JNK activation in brain by anisomycin Possible neuroprotective role in cerebral ischemia. Society for Neuroscience Abstracts 22(1-3): 1673
Kyriakis, J.M.; Banerjee, P.; Nikolakaki, E.; Dai, T.; Rubie, E.A.; Ahmad, M.F.; Avruch, J.; Woodgett, J.R. 1994: SAPKs A MAP kinase subfamily that transduces stress and TNF-alpha signals to c-Jun. FASEB Journal 8(7): A1237
Mook Jung, I.; Jung, M.W.; Saitoh, T. 1996: SAPPS neurotrophic activity involves two distinct signaling pathways. Society for Neuroscience Abstracts 22(1-3): 198
Drews, A.L.; Atmar, R.L.; WhiteA.C.Jr.; Wilson, J.; Greenberg, S.B. 1997: SAPS II predicts 30 day mortality in gram negative bacteremia. Clinical Infectious Diseases 25(2): 438
Nandy, P.; Lien, E.J. 1992: SAR analysis of antimitotic natural products affecting microtuble as biotarget for antitumor agents. Pharmaceutical Research (New York) 9(10 Suppl): S102
Lin, M.T.; Liu, K.C.S.C.; Kuo, Y.H.; Chiou, J.F.; Ren, S.; Lien, E.J. 1998: SAR analysis of the Epstein-Barr virus DNA polymerase inhibitors. Chinese Pharmaceutical Journal 50(1): 13-24
Thakur, A.; Thakur, M.; Bharadwaj, A.; Thakur, S. 2008: SAR and QSAR studies: modelling of new DAPY derivatives. European Journal of Medicinal Chemistry 43(3): 471-477
Leone, S.; Mutti, C.; Kazantsev, A.; Sturlese, M.; Moro, S.; Cattaneo, E.; Rigamonti, D.; Contini, A. 2008: SAR and QSAR study on 2-aminothiazole derivatives, modulators of transcriptional repression in Huntington's disease. Bioorganic and Medicinal Chemistry 16(10): 5695-5703
Loi, A.G.; Silvestri, R.; Artico, M.; Massa, S.; Novellino, E.; Greco, G.; Ettorre, A.; Demontis, A.; La Colla, P. 1997: SAR and molecular modeling studies for the anti-HIV-1 activity optimization of pyrryl-aryl-sulphones Identification of derivatives with improved potency. Antiviral Research 34(2): A55
Li, A.H.; Moro, S.; Melman, N.; Ji, X.D.; Jacobson, K.A. 1998: SAR and molecular modeling studies of pyridine derivatives as selective A3 adenosine antagonists. Abstracts of Papers American Chemical Society 216(1-3): MEDI 93
Sheppard, G.S.; Davidsen, S.K.; Fesik, S.W.; Steinman, D.H.; Carrera, G.M.; Florjancic, A.S.; Hajduk, P.J.; Shuker, S.B.; Olejniczak, E.T.; Nettesheim, D.; Meadows, R.P.; Nagy, I.; Marcotte, P.; Magoc, T.J.; Morgan, D.W.; Summers, J.B. 1997: SAR by NMR as a novel tool for lead generation Discovery of a potent series of non-peptide inhibitors of stromelysin. Abstracts of Papers American Chemical Society 213(1-3): MEDI 81
Yong, S.L.; Abraham, S.; Pugsley, M.K.; Hayes, E.S.; Zolotoy, A.B.; Walker, M.J.A. 1996: SAR evidence that antiarrhythmic activity is unrelated to opioid kappa agonist activity. British Journal of Pharmacology 119(Proceedings Suppl ): 117P
Arlt, M.; Bartoszyk, G.D.; Berthelon, J.J.; Boettcher, H.; Brunet, M.; Seyfried, C.A.; Zeiller, J.J. 1997: SAR for new bisarylmethylamine dopamine D-4 antagonists. Society for Neuroscience Abstracts 23(1-2): 685
Boettcher, H.; Bartoszyk, G.D.; Berthelon, J.J.; Brunet, M.; Devant, R.; Greiner, H.E.; Gottschlich, R.; Maerz, J.; Seyfried, C.A.; Zeiller, J.J. 1996: SAR for novel chromanes Atypical neuroleptics with 5HT1A agonistic and D2 antagonistic activity. Society for Neuroscience Abstracts 22(1-3): 841
Rosenkranz, H.S. 1997: SAR in predictive toxicology Reality, distant goal or adjunct?. Mutation Research 379(1 Suppl 1): S13
Wiley, M.R.; Borromeo, P.S.; Coffman, W.J.; Craft, T.J.; Gifford Moore, D.; Lugar, C.W.; Schacht, A.L.; Shuman, R.T.; Smith, G.F.; Weir, L.C.; Wikel, J.H. 1996: SAR investigations on the N-terminus of tripeptide arginal thrombin inhibitors. Abstracts of Papers American Chemical Society 211(1-2): MEDI 126
Mekenyan, O.G.; Veith, G.D.; Bradbury, S.P.; Zaharieva, N. 1995: SAR models for metabolic activation Stability of organic cation intermediates. Quantitative Structure-Activity Relationships 14(3): 264-269
Rosenkranz, H.S. 1997: SAR models of the SOS Chromotest Mechanistic implications. Mutation Research 379(1 Suppl 1): S203
Cowart, M.; Bennett, M.J.; Gfesser, G.; Bhagwat, S.S.; Kohlhaas, K.L.; Alexander, K.M.; Zhu, C.; Britton, D.; Lynch, J.; Yu, H.; Gunther, K.; KerwinJ.F.Jr.; Kowaluk, E.A. 1997: SAR of a series of nucleoside analogs as adenosine kinase inhibitors. Abstracts of Papers American Chemical Society 213(1-3): MEDI 173
Van Vliet, L.A.; Dijkstra, D.; Tepper, P.G.; Damsma, G.; Wikstrom, H.W. 1995: SAR of new and known compounds in the 2-aminotetralin series with respect to dopamine receptor subtypes. Society for Neuroscience Abstracts 21(1-3): 619
Basha, A.; Ratajczyk, J.D.; Stewart, A.O.; Bell, R.L.; Carter, G.W.; Brooks, C.D.W. 1995: SAR on acetylenic N-hydroxy ureas Discovery of ABT-761. Abstracts of Papers American Chemical Society 209(1-2): MEDI 184
Sui, Z.; Guan, J.; Hlasta, D.J.; Macielag, M.J.; Foleno, B.D.; Goldschmidt, R.M.; Loeloff, M.J.; Webb, G.C.; Barrett, J.F. 1998: SAR studies of antibacterial diaryltriazoles against bacterial two-component regulatory systems. Abstracts of Papers American Chemical Society 215(1-2): MEDI 39
Bell, M.G.; Winter, M.A.; Crowell, T.A.; Jones, C.D.; Matthews, D.P.; Neel, D.A.; Stephens, T.W.; Shuker, A.J. 1997: SAR studies of beta-3 adrenergic receptor agonists. Abstracts of Papers American Chemical Society 214(1-2): MEDI 80
Berglund, M.; Dalence-Guzmán, M.ía.F.; Skogvall, S.; Sterner, O. 2008: SAR studies of capsazepinoid bronchodilators 3: the thiourea part (coupling region) and the 2-(4-chlorophenyl)ethyl moiety (C-region). Bioorganic and Medicinal Chemistry 16(5): 2529-2540
Dalence-Guzmán, M.ía.F.; Berglund, M.; Skogvall, S.; Sterner, O. 2008: SAR studies of capsazepinoid bronchodilators. Part 1: the importance of the catechol moiety and aspects of the B-ring structure. Bioorganic and Medicinal Chemistry 16(5): 2499-2512
Berglund, M.; Dalence-Guzmán, M.ía.F.; Skogvall, S.; Sterner, O. 2008: SAR studies of capsazepinoid bronchodilators. Part 2: Chlorination and catechol replacement in the A-ring. Bioorganic and Medicinal Chemistry 16(5): 2513-2528
Sercel, A.D.; Song, Y.; Belliotti, T.; Beylin, V.G.; Connor, D.T.; Marlatt, M.E.; Sorenson, R.J.; Unangst, P.C.; Gilbertsen, R.B.; Chan, K.; Schrier, D.J.; Laemont, K.; Okonkwo, G.C.; Guglietta, A.; Bornemeier, D.A.; Dyer, R.D. 1997: SAR studies of substituted di-t-butylphenols as selective COX-2 inhibitors. Abstracts of Papers American Chemical Society 213(1-3): MEDI 72
Zimmerman, C.N.; Lin, K.C.ugn 1997: SAR studies of the leucine portion of Bio-1050, a potent and selective nanomolar antagonist of the integrin VLA-4. Abstracts of Papers American Chemical Society 213(1-3): MEDI 76
Johansson, N.G.; Lind, P.; Noreen, R.; MorinJ.M.Jr.; Ternansky, R.J. 1993: SAR studies optimizing HIV-1 inhibiting activities of LY73497, a new series of non-nucleoside inhibitors of reverse transcriptase. IXTH INTERNATIONAL CONFERENCE ON AIDS and THE IVTH STD WORLD CONGRESS Author IXth International Conference on AIDS in affiliation with the IVth STD World Congress : 34
Kawamura, T.; Tashiro, E.; Yamamoto, K.; Shindo, K.; Imoto, M. 2008: SAR study of a novel triene-ansamycin group compound, quinotrierixin, and related compounds, as inhibitors of ER stress-induced XBP1 activation - I Taxonomy, fermentation, isolation, biological activities and SAR study. Journal of Antibiotics 61(5): 303-311
Kawamura, T.; Tashiro, E.; Shindo, K.; Imoto, M. 2008: SAR study of a novel triene-ansamycin group compound, quinotrierixin, and related compounds, as inhibitors of ER stress-induced XBP1 activation - II Structure elucidation. Journal of Antibiotics 61(5): 312-317
Yong, C.S.; Roberts, J. 1992: SAR study of superoxide dismutase mimetic copper complexes using erythrocyte ghost as membrane model. Pharmaceutical Research (New York) 9(10 Suppl): S105
Ojima, I.; Ma, Z.; Kirikae, T.; Kuduk, S.D.; Slater, J.C.; Takeuchi, C.S.; Bounaud, P.Y.; Kirikae, F.; Nakano, M. 1997: SAR study of taxoids for NO and TNF-alpha production by murine macrophages. Abstracts of Papers American Chemical Society 213(1-3): MEDI 207
Perez, M.; Pallard, I.; Fourrier, C.; Potier, P.; Pauwels, P.J.; Valentin, J.P.; John, G.W.; Halazy, S. 1998: SAR study on close analogs of F 11356 A novel series of highly efficacious and selective H5TH1B/1D receptor agonists for the acute treatment of migraine. Abstracts of Papers American Chemical Society 216(1-3): MEDI 142
Castro, A.; Lin, K.C.ung 1997: SAR study on the phenyl acetyl portion of Bio-1050, a selective and potent VLA-4 antagonist. Abstracts of Papers American Chemical Society 213(1-3): MEDI 77
Narayanan, K.; Huang, C.; Makino, S. 2008: SARS coronavirus accessory proteins. Virus Research 133(1): 113-121
Frieman, M.; Heise, M.; Baric, R. 2008: SARS coronavirus and innate immunity. Virus Research 133(1): 101-112
Graham, R.L.; Sparks, J.S.; Eckerle, L.D.; Sims, A.C.; Denison, M.R. 2008: SARS coronavirus replicase proteins in pathogenesis. Virus Research 133(1): 88-100
Poljak, L.G.; Seum, C.; Mattioni, T.; Laemmli, U.K. 1995: SARS stimulate but do not confer position independent gene expression. Journal of Cellular Biochemistry Suppl 1995(21B): 130
Sims, A.C.; Burkett, S.E.; Yount, B.; Pickles, R.J. 2008: SARS-CoV replication and pathogenesis in an in vitro model of the human conducting airway epithelium. Virus Research 133(1): 33-44
Van Hemert, M.J.; van den Worm, S.H.E.; Knoops, K.èv.; Mommaas, A.M.; Gorbalenya, A.E.; Snijder, E.J. 2008: SARS-coronavirus replication/transcription complexes are membrane-protected and need a host factor for activity in vitro. Plos Pathogens 4(5): E1000054
Takahashi, H.; Okazaki, S.; Fujiwara, H. 1996: SART1, a novel family of telomeric repeat associated retrotransposable elements of the silkworm, Bombyx mori. Zoological Science 13(Suppl ): 94
Klozar, J.; Rambousek, P.; Sonka, K.; Weiss, V.; Marek, J. 1998: SAS in acromegaly ENT point of view. Journal of Sleep Research 7(Suppl 2): 136
Cilveti, R.; Tambo, S.; Bes, A.; Comellas, A.; Segarra, F.; Pla, T.; Martinez, C.; Chimeno, E.; Estivill, E. 1994: SAS symptom incidence and recovery after CPAP treatment. Journal of Sleep Research 3(Suppl 1): 45
Michael, M.F.; Barrett, J.S. 1994: SAS/PH-kinetics software for non-compartmental pharmacokinetic analysis and data management. Pharmaceutical Research (New York) 11(10 Suppl): S360
Chevalier,J.M.; Buckles,D.J. 2008: SAS2 a guide to collaborative inquiry and social engagement. Sas2< Sup>: A Guide To Collaborative Inquiry And Social Engagement: 7
Lei, X.; Hall, B.G. 1994: SASA: a simplified, reliable method for allele-specific amplification of polymorphic sites. Biotechniques 16(1): 44-45
Deyoung, M.B.; Siwkowski, A.M.; Hampel, A.E. 1997: SArMV and sCYMYI hairpin ribozymes. Official Gazette of the United States Patent and Trademark Office Patents 1200(2): 1255
Kennett, G.A.; Grewal, S.; D'darcy, S.; Wood, M.D.; Glen, A.; Baxter, G.; Murphy, O.; Forbes, I.; Gadre, A.; Blackburn, T.P. 1994: SB 200646 A selective 5-HT-2C receptor antagonist in vivo with anxiolytic efficacy. British Journal of Pharmacology 111(Proceedings Suppl JAN ): 162P
Wood, M.D.; Glen, A.; Murphy, O.; Stewart, B.R.; Blackburn, T.P. 1994: SB 200646A A selective 5-HT-2C receptor antagonist. British Journal of Pharmacology 111(Proceedings Suppl JAN ): 144P
Barone, F.C.; Lysko, P.G.; Price, W.J.; Al Baracanji, K.A.; Benham, C.D.; Harrison, D.C.; Harries, M.H.; Bailey, S.J.; Feuerstein, G.Z.; Hunter, A.J. 1996: SB 201823-A A novel neuronal calcium channel blocker that reduces focal ischemic injury in rats and mice. Stroke 27(1): 188
Clark, M.S.G.; Brown, F.; Harries, M.; Hatcher, J.; Hawkins, J.; Loudon, J.M.; Noy, G.; Riley, G. 1996: SB 202026 A muscarinic partial agonist with functional selectivity for M-1 receptors. Neurobiology of Aging 17(4 Suppl): S161
Gray, C.; , J.H.; Allsop, D.; Clark, M.S.G.; Roberts, G.W. 1996: SB 202026, a functionally M-1 selective partial agonist alters processing of amyloid precursor protein at the cell surface. Neurobiology of Aging 17(4 Suppl): S30
Loudon, J.M.; Hatcher, J.P.; Storey, V.J.; Clark, M.S.G. 1996: SB 202026, a functionally selective M-1 partial agonist, enhances cognition at doses which do not induce side effects. Neurobiology of Aging 17(4 Suppl): S30
Gaster, L.M.; Sanger, G.J. 1994: SB 204070 5-HT-4 receptor antagonists and their potential therapeutic utility. Drugs of the Future 19(12): 1109-1121
Wardle, K.A.; Ellis, E.S.; Gaster, L.M.; King, F.D.; Sanger, G.J. 1993: SB 204070 A highly potent and selective 5-HT-4 receptor antagonist. British Journal of Pharmacology 110(Proceedings Suppl OCT ): 15P
Gaster, L.M. 1993: SB 204070 and related analogues Highly potent and selective 5-HT-4 receptor antagonists derived from metoclopramide. Abstracts of Papers American Chemical Society 206(1-2): MEDI 28
Baxter, G.S.; Ellis, E.S.; Forbes, I.T.; Jones, G.E.; Kennett, G.A.; Murphy, O.E.; Tilford, N. 1994: SB 204741 A potent and selective antagonist at 5-HT-2B receptors. British Journal of Pharmacology 114(Proceedings Suppl ): 157P
Thomas, D.R.; Baxter, G.S.; Carey, J.E.; Gager, T.L.; Gale, D.G.; Holland, V.; Muir, A.; Wilson, S.; Wood, M.D. 1996: SB 204741 is a selective antagonist at the cloned human 5-HT-2B receptor stably expressed in HEK 293 cells. British Journal of Pharmacology 117(Proceedings Suppl ): 137P
Blackburn, T.P.; Kennett, G.A.; Baxter, G.S.; Wood, M.D.; Ham, P.; Forbes, J.T. 1995: SB 206553 In vitro and in vivo characterization of a potent 5-HT-2C/2B receptor antagonist. Society for Neuroscience Abstracts 21(1-3): 1125
Wardle, K.A.; Bingham, S.; Ellis, E.S.; Gaster, L.M.; Rushant, B.; Smith, M.I.; Brown, A.M.; Young, T.J.; Sanger, G.J. 1996: SB 207266 The first potent and selective 5-HT-4 receptor antagonist amide with oral activity. British Journal of Pharmacology 117(Proceedings Suppl ): 126P
Wardle, K.A.; Sanger, G.J. 1997: SB 207266 is a potent 5-HT-4 receptor antagonist in human isolated gastrointestinal tissue. British Journal of Pharmacology 120(Proceedings Suppl ): 192P
Kelly, J.; Murdoch, R.D.; Cowley, H.; Webber, D. 1998: SB 207499 , an orally active, novel, second generation PDE4 inhibitor, does not potentiate the cardiovascular effects of nebulised salbutamol when co-administered in healthy male volunteers. European Respiratory Journal 12(Suppl 28): 362S
Barnette, M.S.; Christensen, S.; Underwood, D.C.; Manning, C.D.; Muccitelli, R.; Hay, D.W.P.; Torphy, T.J. 1998: SB 207499, a second generation PDE4 inhibitor suppresses IL-5 production and inhibits the activation of guinea pig eosinophils. European Respiratory Journal 12(Suppl 29): 69s-70s
Griswold, D.E.; Tzimas, M.N.; Badger, A.M.; Gorycki, P.D.; Levandoski, P.A.; Torphy, T.J. 1997: SB 207499, a second generation phosphodiesterase 4 inhibitor, reduces TNFalpha and IL-4 production in vivo. European Respiratory Journal Suppl 10(25): 313S
Brown, A.M.; Young, T.J.; Patch, T.L.; Cheung, C.W.; Kaumann, A.J.; Gaster, L.; King, F.D. 1993: SB 207710, a potent, selective radioligand for 5-HT-4 receptors. British Journal of Pharmacology 110(Proceedings Suppl OCT ): 10P
Kaumann, A.J.; Lynham, J.; Brown, A.M. 1995: SB 207720 labels small-5HT-4 receptor populations in porcine and human atrium. British Journal of Pharmacology 116(Proceedings Suppl ): 39P
Sarau, H.M.; Foley, J.J.; Schmidt, D.B.; Tzimas, M.N.; Martin, L.D.; Daines, R.A.; Chambers, P.A.; Kingsbury, W.D.; Griswold, D.E. 1995: SB 209247, a high affinity LTB4 receptor antagonist demonstrating potent antiinflammatory activity. Advances in Prostaglandin Thromboxane and Leukotriene Research 23: 275-277
Brown, A.M.; Parsons, A.A.; Raval, P.; Porter, R.; Tilford, N.S.; Gager, T.L.; Price, G.W.; Wood, M.D.; Kaumann, A.J.; Young, R.A.; Rana, K.; Warrington, B.H.; King, F.D. 1996: SB 209509 , a potent constrictor of rabbit basilar artery with high affinity and selectivity for human 5-HT-1D receptors. British Journal of Pharmacology 119(Proceedings Suppl ): 110P
Douglas, S.A.; Elliott, J.D.; Ohlstein, E.H. 1994: SB 209760 inhibits the hemodynamic effects of endothelin -1 in the anesthetized rat. FASEB Journal 8(4-5): A42
Feuerstein, G.; Wong, A.; Nichols, A.; Samanen, J.; Stadel, J.M.; Vasko Moser, J.; Koster, P.; Valocik, R. 1996: SB 214857 A novel nm-peptide orally active potent and selective platelet GPIIb/IIIa receptor antagonist In vitro and in vivo pharmacology. Circulation 94(8): I513
Legos, J.J.; Lenhard, S.C.; Haimbach, R.E.; Schaeffer, T.R.; Bentley, R.G.; McVey, M.J.; Chandra, S.; Irving, E.A.; Andrew A Parsons; Barone, F.C. 2008: SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRi used to define treatable stroke model, time to treatment and mechanism of protection. Experimental Neurology 212(1): 53-62
Pozzi, O.; Angelici, O.; Petrone, G.; Petrillo, P.; Clarke, G.D.; Visentin, L.; Farina, C.; Scheideler, M.A.; Dondio, G. 1998: SB 235863, a new non peptidic delta opioid receptor agonist with antihyperalgesic activity. Society for Neuroscience Abstracts 24(1-2): 890
Engels,H. 2008: SB meat improves longer storage. Sus: 60-63
Gaster, L. 1997: SB-207266 N- -3,4-dihydro-2H- oxazino indole-10-carboxamide hydrochloride 5-HT4 receptor antagonist agent for irritable bowel syndrome. Drugs of the Future 22(12): 1325-1332
Silvestre, J.; Graul, A.; Castaner, J. 1998: SB-207499 Antiasthmatic/antiinflammatory phosphodiesterase IV inhibitor. Drugs of the Future 23(6): 607-615
Graul, A.; Leeson, P.; Castaner, J. 1997: SB-209509/VML-251 Antimigraine, 5-HT-1B/1D receptor agonist. Drugs of the Future 22(7): 725-728
Kennett, G.A.; Trail, B.; Riley, G.; Bickerdike, M.J.; Ranson, J.; Forbes, I.T.; Price, G.W.; Baxter, G.S.; Hunter, A.J. 1998: SB-215505, a selective 5-HT2B receptor antagonist in rats. Society for Neuroscience Abstracts 24(1-2): 1371
Selkirk, J.V.; Scott, C.; Ho, M.; Burton, M.J.; Watson, J.; Gaster, L.; Middlemiss, D.N.; Price, G.W. 1997: SB-224289, a selective h5-HT1B receptor antagonist with negative intrinsic activity. British Journal of Pharmacology 122(Proceedings Suppl ): 208P
Campbell, C.A.; Mackay, K.B.; Hadingham, S.J.; King, P.D.; Patel, S.R.; Hamilton, T.C. 1997: SB-238592 does not reduce indices of ischaemic damage following permanent or transient focal cerebral ischaemia in normotensive rats. British Journal of Pharmacology 122(Proceedings Suppl ): 324P
Graul, A.; Castaner, J. 1998: SB-265805/LB-20304a Naphthyridine antibacterial. Drugs of the Future 23(11): 1199-1204,
Duran, N. 1993: SB-73 Immunostimulant. Drugs of the Future 18(4): 327-334
Zheng, Z.; Ma, W.Y.; Huang, C.; Dong, Z. 1998: SB202190 and SB203580 inhibit TPA- or EGF-induced AP-1 activation and cell transformation without inhibition of P38 kinase. Proceedings of the American Association for Cancer Research 39: 406
Zia, V.; Rajewski, R.A.; Stella, V.J. 1997: SBE-betaCDs and HP-beta-CDs Characterization of binding forces involved in complexation. Pharmaceutical Research (New York) 14(11 Suppl): S481
Drmanac, R.; Labat, S.V.D.manacan; Vicentic, A.; Gemmell, A.; Stavropoulos, N.; Jarvis, J. 1993: SBH and the integration of complementary approaches in the mapping, sequencing, and understanding of complex genomes. Lim, H A, Fickett, J W, Cantor, C R, Robbins, R J The Second International Conference on Bioinformatics, Supercomputing, and Complex Genome Analysis 121-134
Decoteau, J.; Griesser, H.; Hawley, R.; Sheridan, B.L.; Pinkerton, P.H.; Reis, M.D. 1993: SBH-1, a novel Reed-Sternberg-like cell line with a t not involving the BCL-2 locus. Blood 82(10 Suppl 1): 524A
Mizutani, A.; Fukuda, M.; Mikoshiba, K. 1998: SBP66, a novel synaptotagmin-binding protein. Society for Neuroscience Abstracts 24(1-2): 1568
Van Der Vlies, S.; Voorter, C.; Van Den Berg Loonen, E. 1998: SBT of the HLA-C locus Detection of the serological Cw blanks. European Journal of Immunogenetics 25(Suppl 1): 47
Meyerhoff, C.; Bischof, F.; Sternberg, F.; Zier, H.; Pfeiffer, E.F. 1992: SC implanted microdialysis probe in conjunction to a glucose sensor enables on line continuous monitoring of subcutaneous tissue glucose in healthy and diabetic persons. International Journal of Artificial Organs 15(9): 523
Falkon, L.; Bayes, M.; Gari, M.; Frontera, G.; Barbanoj, M.; Fontcuberta, J. 1996: SC injection of a new molecular mass heparin within the therapeutical range, in healthy volunteers Kinetic profile of the anti-FIIa and anti-FXa effects. British Journal of Haematology 93(Suppl 2): 8-9
Savage, M.A.; Moummi, C.; Karabatsos, P.J.; Lanthorn, T.H. 1993: SC-46275 A novel highly selective agonist at the putative EP-3 receptor. Gastroenterology 104(4 Suppl): A576
Tsai, B.S.; Keith, R.H.; Villani Price, D.; Kachur, J.F.; Yang, D.C.; Djuric, S.W.; Yu, S. 1993: SC-51146, a potent leukotriene B-4 receptor antagonist. FASEB Journal 7(3-4): A164
Yu, S.S.; Djuric, S.W.; Dygos, J.H.; Tsai, B.S.; Paulson, S.K.; Smith, P.F.; Fretland, D.J. 1994: SC-53228 Antiinflammatory leukotriene B-4 antagonist. Drugs of the Future 19(12): 1093-1097
Hubbard, R.C.; Koepp, R.J.; Yu, S.; Walker, S.T.; Geis, G.S.; Wiesenhutter, C.W.; Makarowski, W.S.; Paulus, H.A. 1996: SC-58635 , a novel COX-2 selective inhibitor, is effective as a treatment for osteoarthritis in a short-term pilot study. Arthritis and Rheumatism 39(9 Suppl): S226
Karim, A.; Tolbert, D.; Burton, E.; Piergies, A.; Harper, K.; Paulson, S.; Schoenhard, G.; Hubbard, R.; Isakson, P.; Geis, S. 1997: SC-58635 A highly selective inhibitor of cyclooxygenase-2, disposition kinetics in man and identification of its major CYP450 isozyme in its biotransformation. Pharmaceutical Research (New York) 14(11 Suppl): S617
Hubbard, R.C.; Mehlisch, D.R.; Jasper, D.R.; Nugent, M.J.; Yu, S.; Isakson, P.C. 1996: SC-58635, a highly selective inhibitor of COX-2, is an effective analgesic in an acute post-surgical pain model. Journal of Investigative Medicine 44(3): 293A
Anton, P.; Kirchner, H.; Stief, C.; Hoefner, K.; Jonas, U.; Atzpodien, J. 1996: SC-interleukin-2 and SC-interferon-alpha therapy in combination with IV 5-fluorouracil in metastatic renal cell carcinoma. Journal of Urology 155(5 Suppl): 384A
Mendis, D.B.; Ivy, G.O.; Brown, I.R. 1994: SC1, a putative brain ECM glycoprotein related to SPARC, is expressed by cerebellar astrocytes following neural injury and during development. Molecular Biology of the Cell 5(Suppl ): 180A
Wang, J.L.; Cheng, H.F.; Harris, R.C. 1998: SC58236, a specific cyclooxygenase-2 inhibitor, decreases renin release in a model of renovascular hypertension. Journal of the American Society of Nephrology 9(Program and Abstr. Issue): 318A
Schmitz-Hübsch, T.; Giunti, P.; Stephenson, D.A.; Globas, C.; Baliko, L.; Saccà, F.; Mariotti, C.; Rakowicz, M.; Szymanski, S.; Infante, J.; van de Warrenburg, B.P.C.; Timmann, D.; Fancellu, R.; Rola, R.; Depondt, C.; Schöls, L.; Zdzienicka, E.; Kang, J.-S.; Döhlinger, S.; Kremer, B.; Melegh, B.; Filla, A.; Klockgether, T. 2008: SCA Functional Index: a useful compound performance measure for spinocerebellar ataxia. Neurology 71(7): 486-492
Burright, E.N.; Clark, H.B.; Servadio, A.; Matilla, T.; Feddersen, R.M.; Yunis, W.S.; Duvick, L.A.; Zoghbi, H.Y.; Orr, H.T. 1995: SCA1 transgenic mice A model for neurodegeneration caused by CAG trinucleotide expansion. American Journal of Human Genetics 57(4 Suppl): A4
Brice, A.; Cancel, G.; Durr, A.; Didierjean, O.; Imbert, G.; Buerk, K.; Saudou, F.; Yvert, G.; Abada, M.; Belal, S.; Benomar, A.; Klockgether, T.; Mandel, J.L.; Agid, Y. 1997: SCA2 Another unstable CAG expansion Molecular and clinical analysis of 101 patients. Neurology 48(3 Suppl 2): A210
Cancel, G.; Stevanin, G.; Dürr, A.; Chneiweiss, H.; Penet, C.; Pothin, Y.; Agid, Y.; Brice, A. 1995: SCA2 is not a major locus for ADCA type i in French families. American Journal of Medical Genetics 60(5): 382-385
Filla, Alessandro; De Michele, Giuseppe; Santoro, Lucio; Calabrese, Olga; Castaldo, Imma; Giuffrida, Salvo; Serlenga, Luigi; Scala, Rossana; Restivo, Domenico; Caruso, Giuseppe; Cocozza, Sergio 1998: SCA2 is the commonest autosomal dominant cerebellar ataxia in southern Italy A clinical and molecular study in 30 families. Neurology 50(4 Suppl 4): A168-A169
Corydon, M.J.; Bross, P.; Andresen, B.S.; Ribes, A.; Rinaldo, P.; Lehnert, W.; Kmoch, S.; Kristensen, T.J.; Winter, V.S.; Gregersen, N. 1997: SCAD gene point-mutations in patients with ethylmalonic aciduria. Journal of Inherited Metabolic Disease 20(Suppl 1): 52
Zschocke, J.; Gregersen, N.; Lehnert, W.; Koehler, M.; Hoffmann, G.F. 1996: SCAD gene polymorphism G625A in children with neuromuscular or hepatic symptoms and ethylmalonic aciduria. Journal of Inherited Metabolic Disease 19(Suppl 1): 58
Singleton, D.R.; Castle, J.D. 1996: SCAMP 37 defines a family of closely related membrane proteins that are conserved evolutionarily. Molecular Biology of the Cell 7(Suppl ): 433A
Lam, S.Kwan.; Cai, Y.; Hillmer, S.; Robinson, D.G.; Jiang, L. 2008: SCAMPs highlight the developing cell plate during cytokinesis in tobacco BY-2 cells. Plant Physiology 147(4): 1637-1645
Penkina, M.V.; Karpova, O.I.; Zakharevich, N.V.; Sizova, T.V.; Bogdanov, Y., F. 2008: SCAR DNA family is enriched in evolutionarily conserved sequences. Molecular Biology 42(2): 321-327
NiuJianXin; LvJianQiang; WangLin; YeChunXiu; ZhangHuPing; ZhangLuXia 2008: SCAR marker linked to early-bearing genes in walnut. Journal Of Fruit Science: 5, 732-735
Molina, R.; Moragas, M.; Perez, J.; Filella, X.; Torres, M.D.; Joseph, J.; Arias, C.; Jo, J.; Traserra, J.; Ballesta, A.M. 1992: SCC and TPS in patients with head and neck malignancies Prognostic value. Anticancer Research 12(6A): 1827
Fernández-Llamaazares, J.; Encabo, G.; Piñol, M.; Gelonch, J. 1992: SCC antigen in patients with esophageal cancer. International Journal of Biological Markers 7(4): 267
Arlt, A.; Dasbach, M. 1992: SCC associated antigen in follow up of squamous cell carcinomas of the head and neck. Anticancer Research 12(6A): 1827
Windsor, L.J.; Alexander, L.D.; Trummell, H.Q.; Harber, G.J.; Engler, J.A. 1996: SCC-25 mediated collagen degradation. FASEB Journal 10(6): A1131
Duk, J.M.; Groenier, K.H.; Ten Hoor, K.A.; Aalders, J.G.; De Bruijn, H.W.A. 1995: SCC-antigen, a new prognostic factor in cervical cancer. Proceedings of the American Association for Cancer Research 36: 244
Schemmann, F.; Adamietz, I.A.; Baum, R.P.; Knecht, R.; Saran, F.; Mose, S.; Thilmann, C.; Hoer, G.; Boettcher, H.D. 1994: SCC-immuno-SPECT in radiation treatment planning of head and neck cancer. Journal of Cancer Research and Clinical Oncology 120(Suppl ): R36
Urbaschek, R.; Seitz, H.K.; Rudi, V.; Becker, K.P.; Stickel, F.; Urbaschek, B.; Mccuskey, R.S. 1995: SCD14, sICAM-1, cytokines, endotoxin and endotoxin neutralizing capacity during alcoholic liver disease. Gastroenterology 108(4 Suppl): A1190
Roussou, E.; Gordon, J.; Farr, M.; Gordon, C.; Emery, P.; Bacon, P.A. 1992: SCD23 as a marker of activity in rheumatic disease. Arthritis and Rheumatism 35(9 Suppl): S310
Berte, F.; Vastola, M.B.; Arruzzoli, F.; Stillittano, M.; Fiorello, G.; Girbino, G. 1996: SCD23 in adverse drug reactions. Allergy 51(Suppl 31): 75
Merendino, A.; Chiappara, G.; Vignola, A.M.; Di Pietro, V.; Amoroso, S.; Bellia, V.; Bonsignore, G. 1994: SCD23 levels as a marker of activity in atopic diseases. European Respiratory Journal 7(Suppl 18): 456S
Musatti, C.; Daher, S.; Guirau, L.; Sole, D.; Naspitz, C.K. 1993: SCD23 serum levels in atopic and non-atopic children. Journal of Allergy and Clinical Immunology 91(1 Part 2): 179
Desablens, B.; Capiod, J.C.; Gouilleux, V.; Fuentes, V.; Garidi, R.; Claisse, J.F.; Prin, L. 1996: SCD23, sCD25, LDH or beta-2-microglobulin? What is the best prognostic factor in B-CLL?. Blood 88(10 Suppl 1 Part 1-2): 243A
Tendian, S.W.; Brouillette, C.G. 1993: SCD4 stability measured by calorimetry and guanidine hydrochloride denaturation. Biophysical Journal 64(2 Part 2): A174
Jochum, M.; Inthorn, D.; Schorr, M.; Waydhas, C.; Weichselbraun, I.; Fritz, H. 1995: SCD44var Is it a reliable tumor marker?. Journal of Cellular Biochemistry Suppl 1995(19B): 27
Cavazzana Calvo, M.; Hacein Bey, S.; De Saint Basile, G.; Le Deist, F.; Fischer, A. 1996: SCF and IL-15 restore natural killer cell differentiation from gamma-C transduced SCID X1 bone marrow cells. Blood 88(10 Suppl 1 Part 1-2): 161A
Karimi, K.; Redegeld, F.A.; Heijdra, B.; Niikamp, F.P. 1998: SCF and IL-4 induce development of connective tissue type mast cells from murine bone marrow in vitro. FASEB Journal 12(5): A895
Agis, H.; Sperr, W.R.; Willheim, M.; Spanbloechl, E.; Bankl, H.C.; Lechner, K.; Boltz Nitulescu, G.; Valent, P. 1993: SCF receptor epitope mapping on mast cells using mAb to extracellular domains of c-kit. Tissue Antigens 42(4): 328
Smith, M.A.; Singer, C.R.J.; Smith, J.G. 1995: SCF synergises with G+GM-CSF and IL-3 to increase sensitivity of AML and normal marrow progenitors to Ara-C in vitro An effect independent of cell surface cytokine receptor levels. Blood 86(10 Suppl 1): 704A
D.H.an, G.; Dontje, B.; Loeffler, M.; Nijhof, W. 1993: SCF treatment prevents the mutual inhibition of granulopoiesis and erythropoiesis, induced by EPO and G-CSF. Blood 82(10 Suppl 1): 232A
Toa, M.; Li, B.; Yang, J.; Andrews, C.; Chen, Y.; Nayini, J.; Venugopal, P.; Preisler, H.D. 1998: SCF, IL1beta, IL1RA, and GMCSF in the bone marrow and serum of normal, individuals and AML patients. Blood 92(10 Suppl 1 Part 1-2): 607A
Button, C.L.; Galli, S.J.; Coleman, J.W. 1998: SCF-induced production of TNF-alpha by mast cells Evidence for regulation by nitric oxide. Immunology 95(Suppl 1): 20
Huang, B.; Lei, Z.; Zhang, G.-M.; Li, D.; Song, C.; Li, B.; Liu, Y.; Yuan, Y.; Unkeless, J.; Xiong, H.; Feng, Z.-H. 2008: SCF-mediated mast cell infiltration and activation exacerbate the inflammation and immunosuppression in tumor microenvironment. Blood 112(4): 1269-1279
Charney, A.N.; Giannella, R.A. 1997: SCFAS but not intracellular bicarbonate inhibit cyclic GMP-mediated secretion. Gastroenterology 112(4 Suppl): A353
Charney, A.N.; Egnor, R.W.; Giannella, R.A. 1998: SCFAs prevent and reverse cGMP -induced colonic CL- secretion. Gastroenterology 114(4 Part 2): A358-A359
Roach, S.; Cady, R.; Brand, M.; Wicks, B.; Murray, P. 1996: SCFE Classification by fluoroscopic stability. Pediatrics 98(3 Part 2): 555
Finnem, R.; Marks, J.D. 1996: SCFV antibody fragments for breast tumor targeting. Immunotechnology 2(4): 285
Carlson, S.L.; Parrish, M. 1996: SCG neurite outgrowth modulated by co-culture with spleen. Society for Neuroscience Abstracts 22(1-3): 747
Mattingly, B.A.; Bonta, T.; Himmler, C.; Woods, J.; Jones, J. 1998: SCH 23390 does not block the development of behavioral sensitization to 7-OH-DPAT. Society for Neuroscience Abstracts 24(1-2): 1436
Martin, M.W.; Scott, A.W.; Griffin, S.A.; Chumpradit, S.; Kung, H.F.; Elder, S.T.; Mach, R.H.; Luedtke, R.R. 1995: SCH 23390 is a partial agonist at rat D1A and D1B dopamine receptors expressed in SF9 cells. Society for Neuroscience Abstracts 21(1-3): 1118
Kohn, O.F.; Mitchell, P.P.; Steinmetz, P.R. 1992: SCH 28080 inhibits proton secretion by turtle urinary bladder independent of luminal potassium. Journal of the American Society of Nephrology 3(3): 780
Jayaram, A.; Singh, P.; Vadhera, R.; Carp, H. 1994: SCH 32615, and enkephalinase inhibitor, enhances pregnancy induced analgesia in mice. Anesthesia and Analgesia 78(2 Suppl): ABSTRACT S176
Tice, M.A.B.ck; Hashemi, T.; Taylor, L.A.; Grandy, D.K.; Mcquade, R.D. 1993: SCH 39166 affinity for the cloned dopamine receptors. Society for Neuroscience Abstracts 19(1-3): 76
Koo, John, Y.M. 1993: SCH 40120, A novel leukotriene and cytokine inhibitor, in the treatment of psoriasis vulgaris. Journal of Investigative Dermatology 101(3): 471
Sybertz, E.J.; Davis, H.R.; Van Heek, M.; Burrier, R.E.; Salisbury, B.G.; Romano, M.T.; Clader, J.W.; Burnett, D.A. 1995: SCH 48461, a novel inhibitor of cholesterol absorption. Woodford, F P, Davignon, J, Sniderman, A International Congress Series; Atherosclerosis X 311-315
Snead, O.C.rter IIi; Liu, C.C.; Kreutner, W.; Wang, Y.; Hosford, D.A. 1995: SCH 50911, a specific GABA-B receptor antagonist is a potent antiabsence drug in experimental generalized absence seizures. Neurology 45(4 Suppl 4): A362
Fromtling, R.A.; Castaner, J. 1995: SCH 51048 Antifungal. Drugs of the Future 20(3): 241-247
Kumar, C.C.; Walsh, A.; Bar Sagi, D. 1998: SCH 51344 reverses RAS-transformation by specifically inhibiting RAS and RAC-mediated cell morphology pathway. Kuzumaki, N Author Hokkaido University Medical Library Series; Cytoskeleton and G-proteins in the regulation of cancer 158-161
Kirkup, M.P.; Rizvi, R.; Shankar, B.B.; Dugar, S.; Clader, J.W.; Mccombie, S.W.; Lin, S.I.; Yumibe, N.; Huie, K.; Van Heek, M.; Compton, D.S.; DavisHarry, R.Jr; Mcphail, A.T. 1996: SCH 57939 Synthesis and pharmacological properties of a potent, metabolically stable cholesterol absorption inhibitor. Bioorganic and Medicinal Chemistry Letters 6(17): 2069-2072
Gessi, S.; Varani, K.; Dionisotti, S.; Ongini, E.; Borea, P.A. 1998: SCH 58261 labels functional adenosine A2A receptors in human neutrophil membranes. Drug Development Research 43(1): 45
Zocchi, C.; Ongini, E.; Baraldi, P.G.; Dionisotti, S. 1994: SCH 58261, A new potent and selective adenosine A-2a receptor antagonist. British Journal of Pharmacology 114(Proceedings Suppl ): 299P
Phife, D.W.; Patton, R.W.; Berrie, R.L.; Yarborough, R.; Puar, M.S.; Patel, M.; Bishop, W.R.; Coval, S.J. 1995: SCH 58450, a novel farnesyl protein transferase inhibitor possessing a 6a,12a7,12-diepoxybenz anthracene ring system. Tetrahedron Letters 36(39): 6995-6998
Ho, G.D.; Tulshian, D.; Bercovici, A.; Silverman, L.; Puchalski, C.; Xia, Y.; Czarniecki, M.; Green, M.; Watkins, R.; Vemulapalli, S.; Davis, H. 1996: SCH 59498 A potent inhibitor of cGMP selective phosphodiesterases. Abstracts of Papers American Chemical Society 212(1-2): MEDI 165
Liu, M.; Lee, S.; Yaremko, B.; Chen, J.; Dell, J.; Nielsen, L.; Lipari, P.; Ferrari, E.; Malkowski, M.; Bryant, M.S.; Njoroge, F.G.; Taveras, A.G.; Doll, R.J.; Kirschmeier, P.; Nomeir, A.A.; Kelly, J.; Remiszewski, S.; Mallams, A.K.; Afonso, A.; Hollinger, F.P.; Cooper, A.B.; Liu, Y.T.; Ra 1998: SCH 66336, an orally bioavailable tricyclic farnesyl protein transferase inhibitor, demonstrates broad and potent in-vivo antitumor activity. Proceedings of the American Association for Cancer Research 39: 270
Kirschmeier, P.; Carr, D.; Gray, K.; James, L.; Patton, R.; Mcguirk, M.; Doll, R.J.; Njoroge, F.G.; Taveras, A.; Remiszewski, S.; Mallams, A.K.; Kelly, J.; Girijavallabhan, V.; Cooper, A.B.; Ganguly, A.K.; Bishop, W.R. 1998: SCH 66336, an orally bioavailable tricyclic farnesyl transferase inhibitor blocks anchorage-independent growth of Ras-transformed fibroblasts and human tumor cell lines. Proceedings of the American Association for Cancer Research 39: 318
Crowley, M.T.; Harmer, S.L.; De Franco, A.L. 1995: SCH and SYK associated P145 becomes tyrosine phosphorylated in response to multiple cell stimuli. 9TH INTERNATIONAL CONGRESS OF IMMUNOLOGY Author The 9th International Congress of Immunology : 693
Oda, A.; Druker, B.J.; Miyakawa, Y.; Watanabe, R.; Handa, M.; Watanabe, K.; Ikeda, Y. 1994: SCH is a major protein tyrosine phosphorylated protein in human platelets, and is associated with triton X-100 insoluble residue. Blood 84(10 Suppl 1): 534A
Fromtling, R.A.; Castaner, J. 1996: SCH-56592 Antifungal. Drugs of the Future 21(2): 160-166
Coughlin, L.J.; O'neal, A.L.; Rizer, R.L.; Jordan, W.P. 1998: SCH23390 pre-treatment blocks cocaine sensitized head bobbing in rats. Society for Neuroscience Abstracts 24(1-2): 2134
Gale, J.D.; Kullar, H.S.; Bunce, K.T. 1994: SCH23390 relaxes the rat thoracic oesophagus tunica muscularis mucosae through a 5-HT-4 receptor-mediated mechanism. British Journal of Pharmacology 113(Proceedings Suppl ): 134P
Mchugh, D.T.; Coffin, V.L. 1993: SCH39166, a D1 receptor antagonist, selectively blocked a cocaine-induced increase in spontaneous locomotor activity in mice. Society for Neuroscience Abstracts 19(1-3): 1847
Graybill, J.R.; Bocanegra, R.; Najvar, L.K.; Luther, M.F.; Loebenberg, D. 1998: SCH56592 treatment of murine invasive aspergillosis. Journal of Antimicrobial ChemoTherapy 42(4): 539-542
Coval, S.J.; Puar, M.S.; Phife, D.W.; Terracciano, J.S.; Patel, M. 1995: SCH57404, an antifungal agent possessing the rare sodaricin skeleton and a tricyclic sugar moiety. Journal of Antibiotics 48(10): 1171-1172
Coffin, V.L.; Carey, G.J.; Cohen Williams, M.; Lachowicz, J.; Billard, W.; Binch, H.; Crosby, G.; Morgan, C.; Lowe, D. 1998: SCH57790, a selective M2 receptor antagonist, releases acetylcholine and produces behavioral effects consistent with cognitive enhancement. Society for Neuroscience Abstracts 24(1-2): 182
Liu, M.; Chen, P.; Lee, S.; Li, Z.; Bishop, W.R.; Kirschmeir, P.; Doll, R.J.; Mallams, A.K.; Rossman, R.R.; Dell, J.; Lipari, P.; Malkowski, M.; Prioli, N.; Catino, J.J. 1997: SCH59228, a novel tricyclic inhibitor of farnesyl protein transferase, potently blocks the growth of Ras transformed fibroblasts and human tumor cell lines in nude mice. Proceedings of the American Association for Cancer Research 38: 349
Zuo, X. 1994: SCIC fast separation of anions with indirect ultraviolet detection. Acta Scientiarum Naturalium Universitatis Normalis Hunanensis 17(4): 91-94
Resta, R.; Thompson, L.F. 1997: SCID: the role of adenosine deaminase deficiency. Immunology Today 18(8): 371-374
Duchosal, M.A. 1992: SCID mice in the study of human autoimmune diseases. Springer Seminars in Immunopathology 14(2): 159-177
Martino, G.; Grimaldi, L.M.E. 1997: SCID mouse modeling of human autoimmune diseases. Lefkovits, I Immunology Methods Manual, Vol 3 1817-1828
Schwarz, K.; Ludwig, L.; Lindner, D.; Busch, C.; Hansen Hagge, T.E.; Bartram, C.R. 1994: SCID patients with mutations of the recombinase activating genes 1 and 2. British Journal of Haematology 87(Suppl 1): 115
Morales, M.; Bakshi, S.; Patrick, S.; Pahwa, S. 1998: SCID variants with unusual immunologic presentation. FASEB Journal 12(5): A893
Stoddart, C.A.; Bogan, M.R.; Moreno, M.E.; Linquist, V.D.; Warren, S.; Mccune, J.M. 1997: SCID-hu Thy/Liv mouse model for in vivo human CMV antiviral evaluation. Antiviral Research 34(2): A85
Yurasov, S.; Kollmann, T.; Raker, C.; Kim, A.; Goldstein, H. 1996: SCID-hu mice as an in vivo model for gene therapy of human hematopoietic and lymphoid system. British Journal of Haematology 93(Suppl 2): 338
Li, X.; Fox, J.G.; Whary, M.T.; Yan, L.; Shames, B.; Zhao, Z. 1998: SCID/NCr mice naturally infected with Helicobacter hepaticus develop progressive hepatitis, proliferative typhlitis, and colitis. Infection and Immunity 66(11): 5477-5484
Deneris, E.; Fyodorov, D.; Yang, X. 1995: SCIP is a specific activator of the acetylcholine receptor alpha-3 gene in PC12 cells but activation is not influenced by POU-domain binding sites positioned upstream of the gene. Society for Neuroscience Abstracts 21(1-3): 832
Jackson, C.; Weinstein, D. 1996: SCIP regulates its own expression during myelination. Molecular Biology of the Cell 7(Suppl ): 315A
Green, A.R.; Murrell, A.; Bockamp, E.O.; Spooner, E.; Heyworth, C.; Cross, M. 1993: SCL and gata-1 are coexpressed in multi-potential IL3-dependent progenitors and downregulated during granulocyte/macrophage differentiation. Journal of Cellular Biochemistry Suppl 1993(17 Part A): 159
Lahlil, R.; Krosli, G.; Romeo, P.H.; Krystal, G.; Hoang, T. 1998: SCL function is critical for erythroid differentiation and suppression of apoptosis by erythropoietin. Blood 92(10 Suppl 1 Part 1-2): 195A
Krosl, G.; He, G.; Lefrancois, M.; Caceres Cortes, J.R.; Hoang, T. 1997: SCL is essential for steel factor mediated survival of CD34+ cells. Blood 90(10 Suppl 1 Pt 1): 570A
Lecuyter, E.; Hoang, T. 1998: SCL mediated transcriptional regulation of the c-kit promoter. Blood 92(10 Suppl 1 Part 1-2): 571A
Aplan, P.D.; Jones, C.; Chervinsky, D.S.; Gross, K. 1995: SCL transgenic mice display developmental abnormalities. Proceedings of the American Association for Cancer Research 36: 563
Lesauter, J.; Lehman, M.N.; Silver, R. 1993: SCN transplants are sufficient to sustain circadian locomotor rhythms in hamsters. Society for Neuroscience Abstracts 19(1-3): 1056
Stopa, E.G.; Harper, D.; Kuo Leblanc, V.; Rodriguez Wolf, A.M.; Volicer, L.; Satlin, A. 1994: SCN vasopressin neuron loss in Alzheimers disease in associated with an increased astrocyte/neuron ratio. Society for Neuroscience Abstracts 20(1-2): 158
Donevan, S.D.; Carlson, N.G.; Rogawski, M.A. 1996: SCN- block of AMPA receptors Interaction with the cyclothiazide binding site. Society for Neuroscience Abstracts 22(1-3): 1280
Josselyn, S.A.; Vaccarino, F.J. 1992: SCN/MPOA microinjection of GRF and NPY preferentially increase the consumption of sugar-sweetened chow in rats Similarity to morphine effect suggests common underlying reward mechanism. Society for Neuroscience Abstracts 18(1-2): 895
Shan, L.; Makita, N.; Xing, Y.; Watanabe, S.; Futatani, T.; Ye, F.; Saito, K.; Ibuki, K.; Watanabe, K.; Hirono, K.; Uese, K.; Ichida, F.; Miyawaki, T.; Origasa, H.; Bowles, N.E.; Towbin, J.A. 2008: SCN5A variants in Japanese patients with left ventricular noncompaction and arrhythmia. Molecular Genetics and Metabolism 93(4): 468-474
Boswell, K.D.B.; Gladue, R.; Prima, B.; Kyle, D.J. 1992: SCO Production by fermentative microalgae. Kyle, D J, Ratledge, Conlin Industrial applications of single cell oils: 274-286
Ramel, C. 1996: SCOPE project evaluation of the role and distribution of mercury on ecosystems with special emphasis on tropical regions. Baeyens, W, Ebinghaus, R, Vasiliev, O NATO ASI Series Series 2 Environment; Global and regional mercury cycles: Sources, fluxes and mass balances: 505-513
Legurun, S.; Bergonzelli, G.E.; Blum, A.L.; Corthesy Theulaz, I.E. 1997: SCOT genes and enzymatic activity are present in all Helicobacter pylori strains. Gastroenterology 112(4 Suppl): A197
Bergonzelli, G.E.; Haas, R.; Bachmann, D.; Blum, A.L.; Corthesy Theulaz, I.E. 1997: SCOT is an essential activity for Helicobacter pylori survival in vivo and a potential target for drug therapy. Gastroenterology 112(4 Suppl): A71
Bergonzelli, G.E.; Haas, R.; Bachmann, D.; Blum, A.L.; Corthesy Theulaz, I.E. 1997: SCOT is an essential activity for in vivo survival of Helicobacter pylori. Abstracts of the General Meeting of the American Society for Microbiology 97: 40
Teyra, J.; Paszkowski-Rogacz, M.; Anders, G.; Pisabarro, M.T. 2008: SCOWLP classification: structural comparison and analysis of protein binding regions. Bmc Bioinformatics 9: 9
Atalla, M.M. 1995: SCP Production from methanol as sole source of carbon using fungi. Egyptian Journal of Microbiology 28(3): 321-330
Willems, J.L.; Zywietz, C.; Rubel, P.; Degani, R.; Macfarlane, P.W.; Van Bemmel, J.H. 1992: SCP-ECG A standard communications protocol for computerized electrocardiography. Noothoven van Goor, J , Christensen, J P Studies in Health Technology and Informatics; Advances in medical informatics: Results of the AIM Exploratory Action : 325-332
Miller, M.W.; Rosen, S.C.; Cropper, E.C.; Schissel, S.L.; Kupfermann, I.; Weiss, K.R. 1992: SCP-containing radula mechanoafferent neurons in the buccal ganglion of Aplysia Response properties and biochemical characterization. Society for Neuroscience Abstracts 18(1-2): 1279
Rosen, S.C.; Miller, M.W.; Weiss, K.R.; Kupfermann, I. 1992: SCP-containing radula mechanoafferent neurons in the buccal ganglion of Aplysia Synaptic connectivity of identified cells. Society for Neuroscience Abstracts 18(1-2): 1279
Borovikov, D.; Rosen, S.C.; Cropper, E.C. 1997: SCP-containing sensory neurons in Aplysia are peripherally activated as a result of motor neuron activity. Society for Neuroscience Abstracts 23(1-2): 1045
Khan, H.R.; Price, D.A.; Doble, K.E.; Greenberg, M.J.; Saleuddin, A.S.M. 1995: SCP-like material in the CNS and reproductive system of Helisoma Localization and likely actions. American Zoologist 35(5): 6A
Kawasaki, K.; Weiss, K.M. 2008: SCPP gene evolution and the dental mineralization continuum. Journal of Dental Research 87(6): 520-531
Kurgan, L.; Cios, K.; Chen, K. 2008: SCPRED: accurate prediction of protein structural class for sequences of twilight-zone similarity with predicting sequences. Bmc Bioinformatics 9: 226
Reich, G.; Doble, K.E.; Greenberg, M.J. 1996: SCPb-induced phosphorylation of a 53 kD protein in isolated myocardial cells of Helix aspersa. Society for Neuroscience Abstracts 22(1-3): 836
Levin, J.L.; MarshHenry, C.Jr.; Rudolph, A.R. 1996: SCR1, a novel complement inhibitor Development and potential applications for treating hyperacute rejection of transplanted organs. Lieberman, R , Mukherjee, A Principles of drug development in transplantation and autoimmunity 695-702
Kanaoka, M.M.; Pillitteri, L.J.; Fujii, H.; Yoshida, Y.; Bogenschutz, N.L.; Takabayashi, J.; Zhu, J.-K.; Torii, K.U. 2008: SCREAM/ICE1 and SCREAM2 specify three cell-state transitional steps leading to arabidopsis stomatal differentiation. Plant Cell 20(7): 1775-1785
Silva,A.C.F.da; Souza,Z.daS.; Peruch,L.A.M.; Modolon,T.A.; Pereira,A.daS. 2008: SCS365 Cota the first potato cultivar of Santa Catarina State for organic crop systems. Agropecuaria Catarinense: 3, 85-90
Dhond, M.R.; Nguyen, T.T.; Pulido, G.; Conston, S.; Yamamoto, R.; Bommer, W.J. 1998: SClot lysis using diagnostic ultrasound at 75 Mhz. Circulation 98(17): I291
Gillas, C.E.; Benson, S.A. 1998: SClpP and adaptive reversin of lac murants in Escherichia coli. Abstracts of the General Meeting of the American Society for Microbiology 98: 277
Kabat, A.R. 1998: SD Kaicher , Card Catalogue of World-Wide Shells Not suppressed for nomenclatural purposes. Bulletin of Zoological Nomenclature 55(3): 191-193
Horowitz, M.S.; Pehta, J.C. 1998: SD Plasma in TTP and coagulation factor deficiencies for which no concentrates are available. Vox Sanguinis 74(Suppl 1): 231-235
Hara, Y.kio; Sakashita, Ikumi; Tamagawa, Masaji; Nakaya, Haruaki 1994: SD-3212, a new class I and IV anti-arrhythmic drug, inhibits the muscarinic receptor-operated K+ current in guinea-pig atrial cells. Japanese Journal of Pharmacology 64(Suppl 1): 101P
Gauld, J.; Bell, J.; Towers, W.; Miller, D.; Aspinall, R. 1992: SDD land cover and look-back projects. Whitby, M C Land use change: The causes and consequences: 194
Mengozzi,B. 2008: SDF diversifying tractors, combines, grape pickers. Mondo Macchina: 12, 42-44
Hildebrandt, M.; Schabath, R. 2008: SDF-1 CXCL12 in haematopoiesis and leukaemia impact of DPP IV/CD26. Frontiers in Bioscience 13: 1774-1779
Khademi, B.; Razmkhah, M.; Erfani, N.; Gharagozloo, M.; Ghaderi, A. 2008: SDF-1 and CCR5 genes polymorphism in patients with head and neck cancer. Pathology Oncology Research: Por 14(1): 45-50
Scheidweiler, K.; Ritterman, I.; Tang, J.; Fedyk, E.; Springer, T.; Ryan, D. 1998: SDF-1 and its receptor CXCR4 are required for migration of human B cell precursors under stroma and their proliferation in culture. Blood 92(10 Suppl 1 Part 1-2): 24A
Aiuti, A.; Webb, I.J.; Bleul, C.; Springer, T.A.; Guiterrez Ramos, J.C. 1996: SDF-1 is a chemoattractant for human CD34+ progenitor cells and provides a new mechanism to explain their mobilization to peripheral blood. Blood 88(10 Suppl 1 Part 1-2): 455A
Gao, C.; Huan, J. 2008: SDF-1 plays a key role in chronic allograft nephropathy in rats. Transplantation Proceedings 40(5): 1674-1678
Ngo, H.T.; Leleu, X.; Lee, J.; Jia, X.; Melhem, M.; Runnels, J.; Moreau, A.-S.; Burwick, N.; Azab, A.K.; Roccaro, A.; Azab, F.; Sacco, A.; Farag, M.; Sackstein, R.; Ghobrial, I.M. 2008: SDF-1/CXCR4 and VLA-4 interaction regulates homing in Waldenstrom macroglobulinemia. Blood 112(1): 150-158
Guerin, E.; Sheridan, C.; Assheton, D.; Kent, D.; Wong, D.; Grant, M.; Hiscott, P. 2008: SDF1-alpha is associated with VEGFR-2 in human choroidal neovascularisation. Microvascular Research 75(3): 302-307
Smith, B.J. 1997: SDS polyacrylamide gel electrophoresis for N-terminal protein sequencing. Methods in Molecular Biology 64: 17-24
Damiani, F.; Lamkin, M.S.; Setayesh, M.R.; Oppenheim, G.F. 1993: SDS polyacrylamide gel electrophoresis of in vivo acquired enamel pellicle. Journal of Dental Research 72(Special Issue): 362
Smith, B.J. 1994: SDS polyacrylamide gel electrophoresis of proteins. Methods in Molecular Biology 32: 23-34
Hatfield, R.D.; Andrewartha, K.; Stone, B.A. 1996: SDS solubilized lignin complexes from alfalfa stems. Plant Physiology (Rockville) 111(2 Suppl): 147
Anonymous 1996: SDS water hammer employs 1990s technology to put percussion drilling back on the agenda. Petroleum Gazette 31(1): 24-27
Suwanagul,A.; Deewathanawong,R. 2008: SDS-PAGE and two-dimensional electrophoresis determination of protein from peel and pulp tissues of ripening durian fruit. Acta Horticulturae 797: 215-224
Marshall, T.; Williams, K.M.; Ekstrom, J.; Tobin, G.; Bayard, C.; Vesterberg, O. 1993: SDS-PAGE of cat parotid salivary proteins. Biochemical Society Transactions 21(2): 195s
Burton, Z.F.; Kaguni, J.M. 1997: SDS-PAGE of lysate supernatants from induced and uninduced cultures and electrophoretic transfer of proteins to nitrocellulose. Burton, Z F Author, Kaguni, Journal M Author Experiments in molecular biology: Biochemical applications 158-162
Bazzi, C.; Petrini, C.; Rizza, V.; Arrigo, G.; Beltrame, A.; D'amico, G. 1996: SDS-PAGE proteinuric pattern in FSGS, MGN and MPGN Pathophysiological determinants and predictive value on functional outcome. Nephrology Dialysis Transplantation 11(6): A104
Fields, M.W.; Ryals, P.E.; Anderson, K.L. 1995: SDS-PAGE shows polysaccharide inducible membrane proteins from Bacteroides xylanolyticus and Prevotella ruminicola. Abstracts of the General Meeting of the American Society for Microbiology 95: 544
Rohrmann, D.; Mersdorf, A.; Kroeger, K.; Jakse, G.; Mann, H.; Melzer, H. 1997: SDS-electrophoresis A new tool in the evaluation of hydronephrosis. Pediatrics 100(3 Part 2): 537
Bazzi, C.; Petrini, C.; Rizza, V.; Arrigo, G.; Beltrame, A.; D'amico, G. 1996: SDS-page proteinuric pattern in 145 Pts with FSGS, MGN and MPGN Pathophysiological determinants and predictive value on functional outcome. Journal of the American Society of Nephrology 7(9): 1328
Bazzi, C.; Petrini, C.; Rizza, V.; Arrigo, G.; Beltrame, A.; Napodano, P.; D'amico, G. 1998: SDS-page proteinuric pattern predicts progression to chronic renal failure and response to therapy in idiopathic membranous nephropathy. Journal of the American Society of Nephrology 9(Program and Abstr. Issue): 84A
Bazzi, C.; Petrini, C.; Rizza, V.; Napodano, P.; Arrigo, G.; Beltrame, A.; D'amico, G. 1998: SDS-page proteinuric pattern predicts progression to chronic renal failure and response to therapy in primary focal segmental glomerulosclerosis. Journal of the American Society of Nephrology 9(Program and Abstr. Issue): 83A
Judd, R.C. 1996: SDS-polyacrylamide gel electrophoresis of peptides. Walker, J M The protein protocols handbook 101-107
Funderburgh, J.L.; Prakash, S. 1996: SDS-polyacrylamide gel electrophoretic analysis of proteins in the presence of guanidinium hydrochloride. Biotechniques 20(3): 376-378
Sharawy,W.M.; Abdel-Tawab,P.M.; Fahmy,E.M.; Ibraheem,M.R. 2008: SDS-protein and isozyme markers of alfalfa genotypes and their offspring in response to drought and salinity stresses. Biodiversity And Animal Feed: Future Challenges For Grassland Production: Edings Of The 22nd General Meeting Of The European Grassland Federation, Uppsala, Sweden, 9-12 E
Hubbard, C.; Singer, S. 1996: SDS/PAGE analysis of molluscicidal toxins from Bacillus alvei and B circulans. Abstracts of the General Meeting of the American Society for Microbiology 96: 393
Reales, J.M.; Ballesteros, S. 1994: SDT-SP, a program in Pascal for computing parameters and significance tests from several detection theory designs. Behavior Research Methods Instruments and Computers 26(2): 151-155
Meier, C.L.; Koller, M.; Mcallister, K.; Neijt, H.; Urwyler, S.; Wiederhold, K.H. 1996: SDZ 224-208, an orally active AMPA receptor antagonist. Society for Neuroscience Abstracts 22(1-3): 2106
Myers, S.M.; Anderson, P.L.; Damon, R.E.; Verasace, R.W. 1997: SDZ 267-489 for raising serum high density lipoprotein. Abstracts of Papers American Chemical Society 214(1-2): MEDI 219
Markstein, R.; Amstutz, R.; Jaton, A.; Urwyler, S.; Ruedeberg, C.; Imperato, A. 1994: SDZ DOD-647, a new clozapine-like atypical neuroleptic drug. Schizophrenia Research 11(2): 105
Demrow, H.; Batley, C.; Folts, J.D. 1995: SDZ GPI 562, an oral peptidomimetic inhibitor of the platelet GpII-bIII-a abolishes epinephrine and shear induced cyclic flow reductions in stenosed monkey carotid arteries. Journal of the American College of Cardiology 1995(SPEC ISSUE): 70A-71A
Nguyen, A.; Camilleri, M.; Kost, L.J.; Metzger, A.; Hanson, R.B.; Sarr, M.G.; Fett, S.L.; Zinsmeister, A.R. 1996: SDZ HTF919, a nonbenzamide 5HT-4 agonist, stimulates canine colonic motility and transit in vivo. Gastroenterology 110(4 Suppl): A724
Langle, U.W.; Wolf, A.; Ettlin, R. 1998: SDZ ICT 322 induced cataracts in rats and enhancing effect following vitamin E- and selenium-deficient diet. IOVS Investigative Ophthalmology and Visual Science 39(4): S317
Nussbaumer, P.; Winiski, A.P.; Meingassner, J.G.; Cammisuli, S.; Weckbecker, G.; Stutz, A. 1994: SDZ LAP 977 A novel antiproliferative agent derived from the tyrosine kinase inhibitor lavendustin A. Journal of Investigative Dermatology 102(4): 565
Winiski, A.P.; Meingassner, J.G. 1994: SDZ Lap 977 A novel antiproliferative agent-mechanism of action and activity in skin models. Journal of Investigative Dermatology 102(4): 565
Stern, A.; Engelhardt, R.; Foster, C.; Golenbock, D.; Hildebrandt, J.; Landmann, R.; Mayer, P.; Stütz, P. 1995: SDZ MRL 953, a lipid a analog as selective cytokine inducer. Progress in Clinical and Biological Research 392: 549-565
Liehl, E.; Lam, C.; Mayer, P.; Schutze, E.; Bahr, G.; Grossmuller, F.; Stutz, P.; Hildebrandt, J. 1993: SDZ MRL 953, a new cytokine inducing agent and stimulant for nonspecific immunity. Levin, J, Alving, C R, Munford, R S, Stutz, P L International Congress Series; Endotoxin Research, Vol 2 Bacterial endotoxin: Recognition and effector mechanisms: 399-412
Rosenwirth, B.; Billich, A.; Steinkasserer, A.; Peichi, P.; Donatsch, P.; Lawen, A.; Wenger, R.; Traber, P. 1995: SDZ NIM 811 Anti-HIV Nonimmunosuppressive natural cyclosporin. Drugs of the Future 20(6): 579-583
Kalkman, H.O. 1996: SDZ NVI-085, a 5-HT-2C receptor antagonist?. Naunyn-Schmiedeberg's Archives of Pharmacology 353(4): R90
Lacayo, N.J.; Duran, G.E.; Sikic, B.I. 1994: SDZ PSC 833 modulation of resistance to idarubicin in multidrug resistant cell models. Proceedings of the American Association for Cancer Research 35: 352
Michieli, M.; Damiani, D.; Michelutti, A.; Barillari, G.; Ermacora, A.; Melli, C.; Fanin, R.; Silvestri, F.; Russo, D.; Masolini, P.; Baccarani, M. 1996: SDZ PSC 833 restores daunorubicin intracellular content on Ph positive chronic myeloid leukemias in blastic phase. British Journal of Haematology 93(Suppl 2): 351
Viklicky, O.; Zou, H.; Mueller, V.; Szabo, A.; Heemann, U. 1998: SDZ RAD prevents early manifestation of chronic rejection in rat renal allografts. Nephrology Dialysis Transplantation 13(6): A255
Hausen, B.; Boeke, K.; Berry, G.J.; Christians, U.; Morris, R.E. 1998: SDZ RAD, a new rapamycin analogue, effectively suppresses rat lung allograft rejection. Journal of Heart and Lung Transplantation 17(1): 76
Nozulak, J.; Kalkman, H.O.; Floersheim, P.; Hoyer, D.; Buerki, H.R. 1993: SDZ SER 082, a centrally acting and selective 5-HT-2C antagonist. Society for Neuroscience Abstracts 19(1-3): 298
Graul, A.; Castaner, J. 1998: SDZ-ASM-981 Topical treatment for inflammatory skin diseases. Drugs of the Future 23(5): 508-512
Prous, J.; Rabasseda, X.; Castaner, J. 1994: SDZ-ENA-713 Cognition Enhancer Acetylcholinesterase Inhibitor. Drugs of the Future 19: 656-658
Mealy, N.; Cataner, J. 1996: SDZ-FOX-988 Antidiabetic carnitine palmitoyltransferase II inhibitor. Drugs of the Future 21(3): 258-260
Merlin, J.L.; Geurci, A.P.; Marchal, S.; Bour, C.; Colosetti, P.; Kataki, A.; Guerci, O. 1998: SDZ-PSC833 modulation of daunorubicin intracellular accumulation in cells from patients with acute myeloid leukemias. Proceedings of the American Association for Cancer Research 39: 214
Holloway, J.D.; Hall, R. 1998: SE Asian geology and biogeography An introduction. Hall, R , Holloway, J D Biogeography and geological evolution of SE Asia 1-23
Renia, H.; Richardson, S.; Arbuckle, N.; Skea, A. 1996: SE Growers The worlds best seed growing co-operative. American Potato Journal 73(8): 380
Sandberg, A.; Johansson, D.G.A.; Macao, B.; Härd, T. 2008: SEA domain autoproteolysis accelerated by conformational strain: energetic aspects. Journal of Molecular Biology 377(4): 1117-1129
Johansson, D.G.A.; Macao, B.; Sandberg, A.; Härd, T. 2008: SEA domain autoproteolysis accelerated by conformational strain: mechanistic aspects. Journal of Molecular Biology 377(4): 1130-1143
Alpaugh, R.K.; Schultz, J.F.; Mcaleer, C.; Bonjo, C.; Persson, B.; Kopreski, M.; Weiner, L.M. 1998: SEA-targeted immunotherapy Identification of risk factors for toxicity, and evaluation of immune responses in PNU-214565 treated patients. Proceedings of the American Association for Cancer Research 39: 436-437
Szentandrássy, N.; Birinyi, Péter.; Szigeti, G.; Farkas, A.; Magyar, János.; Tóth, Aás.; Csernoch, László.; Varró, Aás.; Nánási, Péter.P. 2008: SEA0400 fails to alter the magnitude of intracellular Ca2+ transients and contractions in Langendorff-perfused guinea pig heart. Naunyn-Schmiedeberg's Archives of Pharmacology 378(1): 65-71
Ekmaharaj,S. 2008: SEAFDEC support to aquaculture programmes in southeast Asian countries. Fao Fisheries Proceedings: , 307-315
Gillham, R. 1996: SEALS A quality of life instrument. Loiseau, P Royal Society of Medicine International Congress and Symposium Series; Lamotrigine: A brighter future 51-56
Enriquez, G.L. 1998: SEAMEO Its role in public health and infectious diseases control. Tropical Medicine 40(4): 171-173
Coleman, J.; Lattimer, N.; Rhodes, K.F.; Ward, T.J. 1994: SEC-579 , a potent and selective 5-HT-3 receptor antagonist that appears non-competitive in studies in the rat isolated vagus nerve. British Journal of Pharmacology 113(Proceedings Suppl ): 136P
Hosobuchi, M.; Kreis, T.; Schekman, R. 1993: SEC21, an essential gene required for ER to Golgi transport, encodes a subunit of a yeast coatomer. Journal of Cellular Biochemistry Suppl 1993(17 Part C): 40
Walch Solimena, C.; Collins, R.N.; Govindan, B.; Novick, P. 1996: SEC2P acts in conjunction with SEC4P to target secretory vesicles in yeast. Molecular Biology of the Cell 7(Suppl ): 440A
Finger, F.P.; Novick, P. 1995: SEC3 genetically interacts with SEC4 and may function at multiple stages of the secretory pathway in Saccharomyces cerevisiae. Molecular Biology of the Cell 6(Suppl ): 396A
Wong, W.; Hammons, H.K.; Willibey, B.D. 1998: SEC3 of polysaccharides. Abstracts of Papers American Chemical Society 216(1-3): AGFD 152
Gillece, P.; Pilon, M.; Romisch, K. 1998: SEC61P mediates peptide transport across the endoplasmic reticulum membrane. Molecular Biology of the Cell 9(Suppl ): 220A
Parra-Coronado,A.; Roa-Mejia,G.; Oliveros-Tascon,C.E. 2008: SECAFE Part I Modeling and mathematical simulation in the mechanical drying of parchment coffee. Revista Brasileira De Engenharia Agricola E Ambiental: 4, 415-427. Ef
Parra-Coronado,A.; Roa-Mejia,G.; Oliveros-Tascon,C.E. 2008: SECAFE Part II Recommendations for the efficient operation of mechanical dryers for parchment coffee. Revista Brasileira De Engenharia Agricola E Ambiental: 4, 428-434
Hussien, E.Mohamed.; Erichsen, T.; Schuhmann, W.; Maciejewska, M. 2008: SECM visualization of the spatial variability of enzyme-polymer spots. 3. Enzymatic feedback mode. Analytical and Bioanalytical Chemistry 391(5): 1773-1782
Raciti, M.; Landi, P.; Pingitore, A.; Marchesi, C.; Picano, E. 1994: SECS Stress echocardiography computerized system for creating a user-friendly data base. European Heart Journal 15(ABSTR Suppl ): 266
Shimoi, H.; IImura, Y.; Ito, K. 1997: SED1P is a major cell wall mannoprotein of Saccharomyces cerevisiae and responsible for lytic enzyme resistance in stationary phase. FASEB Journal 11(9): A1418
Defalque, R.J. 1996: SEE , Wehrmachts miracle drug. Anesthesiology 85(3A): A949
Levesque, M.; Harkness, W.; Sutherling, W.; Schmit, J.; Dewar, S.; EngelJerome, J.; Crandall, P.H. 1992: SEEG localization in epileptic patients who fail localization after noninvasive studies. Epilepsia 33(Suppl 3): 90-91
Morikawa, K.; Mel, B. 1995: SEEMORE A model of object recognition in the extrastriate visual pathways. Society for Neuroscience Abstracts 21(1-3): 662
Llorente Sanchez, S.; Betancourt Pulsan, A.; Ochoa Soto, R.; Coroas Fernandez, R. 1994: Segast. Revista Espanola de Drogodependencias 19(3): 217-228
Magness, C.; Xu, Y.; Green, P. 1994: SEGMAP An interactive computer program for generating YAC-based STS-content maps. Cytogenetics and Cell Genetics 65(1-2): 63
Davey, J. 1994: SEISMED: Secure Environment for Information Systems in Medicine. Computer Methods and Programs in Biomedicine 45(1-2): 153-154
Kim, H.; Bhunia, A.K. 2008: SEL, a selective enrichment broth for simultaneous growth of Salmonella enterica, Escherichia coli O157:H7, and Listeria monocytogenes. Applied and Environmental Microbiology 74(15): 4853-4866
Cheng, L.; Zhou, L.; Tao, L.; Zhang, M.; Cui, J.; Li, Y. 2008: SELDI-TOF MS profiling of serum for detection of laryngeal squamous cell carcinoma and the progression to lymph node metastasis. Journal of Cancer Research and Clinical Oncology 134(7): 769-776
Mangin, B. 1995: SELECT software. CIRAD, Statistical analysis of selection studies: Strategies for the improvement of perennial plants, Traitements statistiques des essais de selection: Strategies d'amelioration des plantes perennes: 297-302
Lal, G.S.; Pez, G.P.; Syvret, R.G. 1993: SELECTFLUOR A safe, effective reagent for the selective electrophilic fluorination of organic substrates. Abstracts of Papers American Chemical Society 206(1-2): ENVR 96
Kim, S.-Kun; Shin, B., C.; Ott, T., A.; Cha, W.; La, I.-Joung; Yoo, M.-Young 2008: SELEX Combinatorial library methodology and applications. BioChip Journal 2(2): 97-102
Allen, P.; Collins, B.; Gold, L. 1994: SELEX-derived RNAs with high affinity and specificity of HIV-1 integrase and nucleocapsid proteins. FASEB Journal 8(7): A1268
Gojic, M. 1993: SEM analysis of fracture surfaces of low alloyed Cr-Mo-Nb steel. Periodicum Biologorum 95(2): 275-276
Randall, P.F.; Gardner, J.S.; Fairbanks, D.J. 1998: SEM analysis of the seed surface morphologies of two varieties of Chenopodium quinoa. American Journal of Botany 85(6): 24
Kodaka, T.; Debari, K.; Mori, R. 1992: SEM and XMA studies of human brain sands. Journal of Electron Microscopy 41(4): 286
Salazar Vallejo, Sergio, I. 1998: SEM and histological evidence of enlarged nephridial papillae in Loandalia Monro. Bulletin - Southern California Academy of Sciences 97(3): 110-114
Rivera Hidalgo, F.; Baker, F.L.; Guillen, G.; Canales, M.L. 1993: SEM dentin tubule changes secondary to fluoride preparations in vitro. Journal of Dental Research 72(Special Issue): 395
Hutchens, L.H.; Pearce, R.B.; Ambrose, W.W. 1993: SEM evaluation of plaque removal with manual vs Interplak brushing. Journal of Dental Research 72(Special Issue): 374
Walshaw, P.R.; Mccomb, D. 1993: SEM evaluation of the resin-dentine interface with proprietary agents in human subjects. Journal of Dental Research 72(Special Issue): 380
Pantanowitz, L.; Fabian, B. 1996: SEM evidence of gonadotropin-induced vitellogenic growth phase in Xenopus laevis oocytes. South African Journal of Science 92(11-12): 565-566
Oganesian, A.; Kohen, L.; Spee, C.; Rao, N.A.; Lopez, P.F. 1994: SEM findings in RPE wound healing in vivo. IOVS Investigative Ophthalmology and Visual Science 35(4): 1764
Hayden, W.John 1992: SEM in the plant anatomy teaching laboratory Stem anatomy of Juncus effusus. Virginia Journal of Science 43(2): 237
Ferk, S.; Anic, S.V.S.govicica; Peric, B. 1996: SEM morphologic changes of the dentin following placement of the self-threading pins. Acta Stomatologica Croatica 30(1): 63-67
Frueh, B.E.; Eggli, P.; Bohnke, M. 1997: SEM morphologies of Lasik with 2 different keratomes. IOVS Investigative Ophthalmology and Visual Science 38(4 Part 1-2): S419
Shafqat, S.; Ahmad, I.; Ahmad, W. 1994: SEM morphology and embryology of Laevides symmetricus. Nematologica 40(4): 534-540
Gardner, L.K.; Steflik, D.E.; Parr, G.R.; Sisk, A.L.; Hanes, P.J.; Brewer, P.; Horner, J. 1993: SEM morphometry of the bone interface to prosthodontically loaded implants. Journal of Dental Research 72(Special Issue): 273
Hirosawa, T.; Saito, T.; Tanaka, T.; Matsushima, H. 1995: SEM observation and HPLC analysis of the accumulation of alpha- and beta-acids in the fresh developing hop peltate glandular trichomes. Journal of Electron Microscopy 44(3): 145-147
Samata, T.; Somiya, H.; Horita, C.; Akera, S. 1994: SEM observation of microcrystals developed over black secretion on the cultured tissue of the pearl oyster Pinctada fucata. Fisheries Science (Tokyo) 60(3): 343-344
Zhang, G.Y.; Xiao, A.X. 1992: SEM observation on antennal sense organs of Spalangia endius and Nasonia vitripennis. Acta Entomologica Sinica 35(2): 154-159
Tahseen, Q.; Ahmad, I.; Jairajpuri, M.S.amim 1993: SEM observations and developmental biology of Tobrilus paludicola Micoletzky, 1925. Nematologica 39(4): 512-520
Jabbari,H.; Niknam,G. 2008: SEM observations and morphometrics of the cabbage cyst nematode, Heterodera cruciferae Franklin, 1945, collected where Brassica spp are grown in Tabriz, Iran. Turkish Journal Of Zoology: 3, 253-262
Chong, S.H.; Mitsushima, A.; Inoue, T.; IIno, A. 1992: SEM observations on the capillary network beneath the epithelium of the rat urinary bladder using sodium hydroxide digestion and vascular corrosion casting. Journal of Electron Microscopy 41(4): 314
E.B.ssery, A.M.; Miyazaki, K.; Mona, M.H.; Kubota, S. 1997: SEM observations on the pedal disc of a commensal hydroid Eugymnanthea japonica with a blue mussel Mytilus edulis galloprovincialis. Zoological Science 14(Suppl ): 37
Fochetti, R. 1994: SEM observations on two Nemoura species of the flexuosa-marginata group N oropensis and N pesarinii. Bollettino dell'Associazione Romana di Entomologia 48(1-4): 27-31
Takagi, S.; Miyatake, Y. 1993: SEM observations on two lerp-forming psylloids. Insecta Matsumurana 1993(49): 69-104
Kleinow, W.; Wratil, H. 1995: SEM of internal structures of Brachionus plicatilis. Hydrobiologia 313-314: 129-132
Das, S.; Ashrafi, S.H.; Das, A.K. 1993: SEM of molybdenum treated rat enamel surface. Journal of Dental Research 72(Special Issue): 236
Peri, G.; Farina, F.; Marciano, V.; Ridola, C.; Diana, G.; Arcara, M.; Guercio, G.; Sommariva, V. 1995: SEM preliminary observations on the ultrastructural aspects of the fascia transversalis at the level of inguinal triangle in the direct inguinal hernia. Acta Anatomica 152(4): 326
Pehlivan, S. 1994: SEM scanning electron microscopic studies of the pollen grains of some Turkish endemic Centaurea. Journal of Faculty of Pharmacy of Gazi University 11(2): 205-211
Yadav, A.K.; Tandon, V. 1993: SEM structure of Bourgelatia diducta. Acta Parasitologica 38(3): 128-130
Ambwani, K.; Kumar, M. 1992: SEM studies of pollen in Nypa fruticans Wurmb. Phytomorphology (Delhi) 41(3-4): 253-255
SushmitaMaity; Datta,A.K.; Maiti,G.G.; Sinha,M.K. 2008: SEM studies of seed and seed coat structure in Corchorus spp. Plant Archives: 2, 627-630
Lizarraga, M.; Illana, C.; Moreno, G. 1999: SEM studies of the Myxomycetes from the Peninsula of Baja California , I Arcyria to Fuligo. Annales Botanici Fennici 35(4): 287-306, Jan 14
Singh, H.B.; Dube, V.P. 1992: SEM studies of the leaves in the family Elaeocarpaceae. Phytomorphology (Delhi) 41(3-4): 257-265
Bandyopadhyay, S.; Thothathri, K. 1996: SEM studies on the testa surface pattern of some species of Bauhinia. Journal of the Bombay Natural History Society 93(1): 116-118
Bandyopadhyay, S.; Thothathri, K. 1996: SEM studies on the testa surface pattern of two species of Bauhinia. Journal of the Bombay Natural History Society 93(1): 120-121
Schramm, U.; Kühnel, W. 1992: SEM studies on unmanageable hair. Archives of Histology and Cytology 55 Suppl: 211-216
Zhang, F.Y.; Gao, Q.K.; Li, S. 1994: SEM studies on wing mirosculpturing of four species of family Termitidae. Acta Entomologica Sinica 37(2): 253-256
Yadav, A.K.; Tandon, V. 1994: SEM study of head and cuticular armature of Gnathostoma doloresi. Acta Parasitologica 39(3): 150-152
Staninec, M.; Marshall, G.W.; Lowe, A. 1993: SEM study of in sbd vivo bonded amalgam restorations. Journal of Dental Research 72(Special Issue): 111
Navarro, M.; Cristofol, C.; Canut, L.; Carretero, A.; Sautet, J.; Arboix, M.; Ruberte, J. 1995: SEM study of the arterial system of the 20 days rat fetus Application in teratology. Teratology 51(6): 27A
Gestal, C.; Abollo, E.; Arias, C.; Pascual, S. 1998: SEM study of the plerocercoid larval Phyllobothrium sp and Nybelinia lingualis , cestode parasite in Octopus vulgaris off Vigo estuary. Iberus 16(1): 125-132
Joseph, K.J. 1991: SEM study of the stridulatory organs in the giant dung beetle Heliocopris dominus with observations on the significance of the sound production. Entomon 16(4): 319-322
Eggli, P.; Boehnke, M.; Epstein, D.; Frueh, B.; Tengroth, B.; Fagerholm, P.; Hoppeler, T.; Gloor, B. 1994: SEM study to compare the ablation characteristics of 5 excimer lasers at a standard -3 and D/5 mm diameter ablation. IOVS Investigative Ophthalmology and Visual Science: 35(4)
Andri, E.; Gerbaudo, S. 1994: SEM use in the study of Bonetocardiella conoidea and Pithonella ovalis. Atti della Societa Italiana di Scienze Naturali e del Museo Civico di Storia Naturale di Milano 133(20): 295-300
Lehuédé, P.; de Meringo, A. 1994: SEM-EDS analysis of glass fibers corroded in physiological solutions by dynamic tests with variable flow rates. Environmental Health Perspectives 102(Suppl 5): 73-75
Sherman, L.R.; Thomas, T.C.; Roberson, K.T. 1993: SEM-EDXA analyses of airborne inorganic fibers for qualitative identification. Abstracts of Papers American Chemical Society 205(1-2): CHAS 32
Martiny, A.; Campos, A.P.C.; Sader, M.S.; Pinto, A.é L. 2008: SEM/EDS analysis and characterization of gunshot residues from Brazilian lead-free ammunition. Forensic Science International 177(1): E9-17
D.J.ng, S.M.; Riezebos, H.T. 1997: SEMMED A distributed approach to soil erosion modelling. Spiteri, A Remote sensing '96 Integrated applications for risk assessment and disaster prevention for the Mediterranean : 199-204
Ball, S.S.; Mah, V.H. 1998: SENEX An electronic resource for molecular neuropathology. Society for Neuroscience Abstracts 24(1-2): 246
Knight, H.; Thomson, A.J.W.; McWatters, H.G. 2008: Sensitive to freezing6 integrates cellular and environmental inputs to the plant circadian clock. Plant Physiology 148(1): 293-303
Chan, I.S.; Goldstein, A.A.; Bassingthwaighte, J.B. 1993: SENSOP: a derivative-free solver for nonlinear least squares with sensitivity scaling. Annals of Biomedical Engineering 21(6): 621-631
Tardif, G.N.; McCalmon, R.T. 1997: SEOPF high-grade HLA match algorithm: effective kidney sharing using ROP trays with HLA matching for highly sensitized patients. Transplantation Proceedings 29(1-2): 1406-1407
Andres, F.G.; Topka, H.; Danner, M.; Baehr, M.; Dichgans, J. 1996: SEP do not support the hypothesis of an afferent deficit in writers cramp. Electroencephalography and Clinical Neurophysiology 99(4): 370
Axford, S.; Hupp, T.R.; Vojtesek, B.; Ross, P.E.; Reynolds, N.; Scobie, G.; Hopwood, D. 1998: SEP-70, a novel oesophageal mucosal heat shock protein Its distribution in normal and pathological tissues. Journal of Pathology 184(Suppl): 17A
Aguglia, U.; Oliveri, R.L.; Gambardella, A.; Talerico, G.; Quattrone, A. 1992: SEP-mapping study in idiopathic partial epilepsies. Neurophysiologie Clinique 22(Suppl 1): 111S
Zaya, M.J.; Shull, K.L.; Brunden, M.N.; Diani, A.R. 1994: SEPA, a novel penetration enhancer, elicits earlier and significantly greater minoxidil-induced hair growth compared to rogaine topical solution in the balding stumptail macaque. Journal of Investigative Dermatology 102(4): 599
James, N.P.; Clarke, J.A.D. 1997: SEPM Special Publication, No 56 Cool-water carbonates. James, N P , Clarke, J A D SEPM (Society for Sedimentary Geology) Special Publication; Cool-water carbonates v+440p
Roark, G.L.; Abraham, R.A.; Harris, A.P. 1994: SEPT sign The use of the sitting epigastric pressure test for diagnosis of post-dural puncture headaches. Anesthesiology 81(3A): A1016
Traversa, R.; Baldinetti, F.; Pierantozzi, M.; Gigli, G.L.; Diomedi, M.; Semprini, R.; Stanzione, P. 1994: SEPs N30 wave modification during sleep related to muscular tonus variation. Journal of Sleep Research 3(Suppl 1): 258
Filippi, M.; Martinelli, V.; Locatelli, T.; Magnani, G.; Galardi, G.; Rovaris, M.; Medaglini, S.; Leocani, L.; Comi, G. 1992: SEPs and MEPs in acute transverse myelopathy of undetermined etiology. Neurophysiologie Clinique 22(Suppl 1): 44S
Swindell, S.R.; Plasterer, T.N. 1997: SEQMAN. Contig assembly. Methods in Molecular Biology 70: 75-89
Huang, C.; Tai, H.H.iung 1995: SER-268 and N-glycosylation play an important role in ligand binding of EP-3 subtype of the prostaglandin E-2 receptor. FASEB Journal 9(3): A116
Longtine, M.S.; Fares, H.; Pringle, J.R. 1994: SER/THR kinases interact with S cerevisiae septins. Molecular Biology of the Cell 5(Suppl ): 414A
Garrett, P.H.; Verin, A.D.; Shu, S.; Garcia, J.G.N. 1997: SER/THR protein phosphatase 1 functional activity in bovine endothelium is regulated by a tyrosine kinase. Journal of Investigative Medicine 45(3): 283A
Gayan Ramirez, G.; Vanzeir, L.; Wuytack, F.; Decramer, M. 1998: SERCA pump alterations in rat diaphragm after corticosteroid treatment. European Respiratory Journal 12(Suppl 28): 452S-453S
Tate, C.; Carroll, J.; Schwarz, L.; Gudikote, J. 1998: SERCA2a and Na/Ca exchanger expression is increased in the hearts of rabbits with experimental obesity. FASEB Journal 12(5): A708
Trost, S.U.; Bluhm, W.F.; Karlon, W.J.; Swanson, E.; Dillmann, W.H. 1998: SERCA2a overexpression improves cardiac performance in diabetic mice. Circulation 98(17): I140
Pfreundschuh, M. 1997: SEREX Using the antibody repertoire of cancer patients for the systematic search of human tumor antigens. Immunology 92(Suppl 1): 11
Eisinger,D.; Wiegand,K. 2008: SERGE a spatially explicit generator of local rainfall in southern Africa. South African Journal of Science 4: 1 2, 39-42
Bucquet, D.; Deveau, C.; Jadand, C.; Boufassa, F.; Belanger, F. 1993: SEROCO French cohort study of HIV-infected adults Description. IXTH INTERNATIONAL CONFERENCE ON AIDS AND THE IVTH STD WORLD CONGRESS IXth International Conference on AIDS in affiliation with the IVth STD World Congress : 663
Zorzetto, M.; Russi, E.; Senn, O.; Imboden, M.; Ferrarotti, I.; Tinelli, C.; Campo, I.; Ottaviani, S.; Scabini, R.; von Eckardstein, A.; Berger, W.; Brändli, O.; Rochat, T.; Luisetti, M.; Probst-Hensch, N. 2008: SERPINA1 gene variants in individuals from the general population with reduced alpha1-antitrypsin concentrations. Clinical Chemistry 54(8): 1331-1338
Providence, K.M.; Higgins, S.P.; Mullen, A.; Battista, A.; Samarakoon, R.; Higgins, C.E.; Wilkins-Port, C.E.; Higgins, P.J. 2008: SERPINE1 (PAI-1) is deposited into keratinocyte migration "trails" and required for optimal monolayer wound repair. Archives of Dermatological Research 300(6): 303-310
Beljebbar, A.; Sockalingum, G.D.; Morjani, H.; Manfait, M. 1998: SERS investigation of the molecular interaction of all-trans and 9-cis retinoic acids with RARs and RXRs nuclear receptors. Proceedings of the American Association for Cancer Research 39: 107
De Vries Robbe, Pieter F.; Benson, Tim J.R.; De Vries, Jaap D.; Graubner, Bernd; Gold, Gerry A.; Orofino, Enrico 1992: SESAME Standardization in Europe on Semantical Aspects of Medicine. Noothoven van Goor, J , Christensen, J P Studies in Health Technology and Informatics; Advances in medical informatics: Results of the AIM Exploratory Action : 333-339
Mankoff, D.A.; Gralow, J.R.; Dunnwald, L.K.; Drucker, M.J.; Ellis, G.; Livingston, R.B. 1996: SESTAMIBI scintimammography to measure the breast cancer response to NEO-adjuvant chemotherapy. Journal of Nuclear Medicine 37(5 Suppl): 252P
Bogler, O.; Furnari, F.B.; Huang, H.J.S.; Cavenee, W.K. 1998: SETA A novel gene expressed in the early stages of astrocytoma formation. Proceedings of the American Association for Cancer Research 39: 273
Papadakis, E.P. 1993: SETI and nemesis An interaction. Speculations in Science and Technology 16(3): 189-191
Dick, S.J. 1996: SETI before the space age. AAAS Annual Meeting and Science Innovation Exposition 162: A55
Maccone, C. 1998: SETI from space and the moon far side in the next century. Chela-Flores, J, Raulin, F Exobiology: Matter, energy, and information in the origin and evolution of life in the universe 355-360
Heidmann, J. 1998: SETI these last few years An interdisciplinary overview. Chela-Flores, J , Raulin, F Exobiology: Matter, energy, and information in the origin and evolution of life in the universe 347-353
Azhakanandam, S.; Nole-Wilson, S.; Bao, F.; Franks, R.G. 2008: SEUSS and AINTEGUMENTA mediate patterning and ovule initiation during gynoecium medial domain development. Plant Physiology 146(3): 1165-1181
ShakuntalaRathore; Bhat,A.; Singh,B.P.; Dwivedi,S. 2008: SEZs - engine of economic growth. Journal Of Applied Biology: 1 2, 77-86
Deviche, P.; Hahn, T.P. 1995: SEasonal reproductive pattern of interior Alaska white-winged crossbills. AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE, ARCTIC DIVISION Author Landscapes: Human ecology, landscape ecology, earth system science : 106
Fernandez, A.; Moler, T.; Guindeo, M.C.; Hortal, L.; Navarro, M.; Vega, N.; Perez Borges, P.; Palop, L. 1998: SErum transferrin receptor Usefulness in anemic chronic renal disease patients. Nephrology Dialysis Transplantation 13(6): A243
Rubinstein, A.; Lewin, G.; Garcia Elorrio, E.; Augustovski, F. 1997: SF-36 is also a valid instrument for outcome measurement among Spanish-speaking people. Jgim 12(Suppl 1): 123
Adams, R.; Ruffin, R.; Smith, B. 1996: SF-36 is not well correlated with asthma quality of life questionnaire in hospital patients Preliminary results from the Western Region Asthma Pilot Project. European Respiratory Journal Suppl. 9(23): 374s
Lechtreck, K.F.; Melkonain, M. 1995: SF-Assemblin, the structural protein of the striated microtubule associated fibers of algal flagellar roots forms a segmented coiled coil. Molecular Biology of the Cell 6(Suppl ): 40A
Stockschlaeder, M.; Eckert, H.G.; Just, U.; Uhde, A.; Grez, M.; Zander, A.; Ostertag, W.; Baum, C. 1996: SF-MDR and MP-MDR, two improved retroviral vectors, conferring high-dose multidrug resistance to primary human hematopoietic progenitor cells. Blood 88(10 Suppl 1 Part 1-2): 430A
Pollack, A.L.; Apodaca, G.; Mostov, K. 1994: SF/HGF affects the morphology and polarity of MDCK epithelial cell monolayers. Molecular Biology of the Cell 5(Suppl ): 74A
Griffiths, P.R.; Norton, K.L.; Bonanno, A.S. 1992: SFC/FT-IR measurements involving elimination of the mobile phase. Jinno, K Journal of Chromatography Library; Hyphenated techniques in supercritical fluid chromatography and extraction: 83-101
Mcnally, M.E.len P.; Deardorff, C.; Hoffman, D. 1993: SFE Does it matter what soil?. Abstracts of Papers American Chemical Society 205(1-2): ENVR 78
Li, Q.X.; Alcantara Licudine, J.P.; Kawate, M.K. 1996: SFE and HPLC determination of xanthene dyes in soil. Abstracts of Papers American Chemical Society 212(1-2): AGRO 4
Riekkola, M.L.; Manninen, P.; Hartonen, K. 1992: SFE, SFE/GC and SFE/SFC Instrumentation and applications. Jinno, K Journal of Chromatography Library; Hyphenated techniques in supercritical fluid chromatography and extraction : 275-304
Zhao, M.; Wetzel, D.L. 1994: SFE/HPLC of wheat flour polar lipids. Cereal Foods World 39(8): 628
Emeryk, B.; Rowinska, K.; Michalska, T.; Strugalska, H. 1992: SFEMG at different firing rates in myasthenia with and without thymoma. Acta Neurobiologiae Experimentalis 52(3): 165
Oh, S.J. 1996: SFEMG in Lambert-Eaton myasthenic syndrome and botulism. Kimura, J, Shibasaki, H International Congress Series; Recent advances in clinical neurophysiology: 292-295
Stalberg, E. 1996: SFEMG, an update. Kimura, J, Shibasaki, H International Congress Series; Recent advances in clinical neurophysiology: 48-60
Rocha, C.L.; Fischetti, V.A. 1997: SFFBP12, a new Streptococcus pyogenes surface protein Characterization and possible role in adherence. Abstracts of the General Meeting of the American Society for Microbiology 97: 36
Drew, K.L.; Ungerstedt, U. 1992: SFK 89976A increases extracellular GABA in rat dorsolateral striatum in vivo. Society for Neuroscience Abstracts 18(1-2): 1001
Hoerber, J.K.H.; Haeberle, W.; Ohnesorge, F.; Binnig, G.; Liebich, H.G.; Czerny, C.P. 1993: SFM and living cells. Marti, O, Amrein, M STM and SFM in biology 309-323
Jantti, J.; Lahdenranta, J.; Soderlund, H.; Keranen, S. 1997: SFS3, a novel conserved gene interacting with components of the exocyst complex in Saccharomyces cerevisiae. Journal of General Physiology 110(1): 29A
Jantti, J.; Keranen, S. 1996: SFS3, a novel gene interacting with SEC8-9 and SEC15-1 members of the exocyst complex in Saccharomyces cerevisiae. Molecular Biology of the Cell 7(Suppl ): 440A
Cherksey, B.; Sugimori, M.; Llinas, R. 1994: SFTX-isolated P-type calcium channel protein is blocked by sFTX and w-Aga-IVA, but not by OMEGA-conotoxin. Society for Neuroscience Abstracts 20(1-2): 630